

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>The emerging role of PET imaging in dementia | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/6-1830/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/6-1830" />
    
            <meta name="description" content="Read the original article in full on F1000Research: The emerging role of PET imaging in dementia" />
    
            <meta name="og:title" content="F1000Research Article: The emerging role of PET imaging in dementia.">
            <meta name="og:description" content="Read the latest article version by Leonardo Iaccarino, Arianna Sala, Silvia Paola Caminiti, Daniela Perani, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="12533">
            <meta name="article-id" content="11603">
            <meta name="dc.title" content="The emerging role of PET imaging in dementia">
            <meta name="dc.description" content="A compelling need in the field of neurodegenerative diseases is the development and validation of biomarkers for early identification and differential diagnosis. The availability of positron emission tomography (PET) neuroimaging tools for the assessment of molecular biology and neuropathology has opened new venues in the diagnostic design and the conduction of new clinical trials. PET techniques, allowing the in vivo assessment of brain function and pathology changes, are increasingly showing great potential in supporting clinical diagnosis also in the early and even preclinical phases of dementia. This review will summarize the most recent evidence on fluorine-18 fluorodeoxyglucose-, amyloid -, tau -, and neuroinflammation - PET tools, highlighting strengths and limitations and possible new perspectives in research and clinical applications. Appropriate use of PET tools is crucial for a prompt diagnosis and target evaluation of new developed drugs aimed at slowing or preventing dementia.">
            <meta name="dc.subject" content="fluorodeoxyglucose, amyloid, tau, neuroinflammation, molecular imaging, diagnosis, prognosis, biomarker, dementia, PET">
            <meta name="dc.creator" content="Iaccarino, Leonardo">
            <meta name="dc.creator" content="Sala, Arianna">
            <meta name="dc.creator" content="Caminiti, Silvia Paola">
            <meta name="dc.creator" content="Perani, Daniela">
            <meta name="dc.date" content="2017/10/12">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.11603.1">
            <meta name="dc.source" content="F1000Research 2017 6:1830">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="fluorodeoxyglucose ">
            <meta name="prism.keyword" content=" amyloid ">
            <meta name="prism.keyword" content=" tau ">
            <meta name="prism.keyword" content=" neuroinflammation ">
            <meta name="prism.keyword" content=" molecular imaging ">
            <meta name="prism.keyword" content=" diagnosis ">
            <meta name="prism.keyword" content=" prognosis ">
            <meta name="prism.keyword" content=" biomarker ">
            <meta name="prism.keyword" content=" dementia ">
            <meta name="prism.keyword" content=" PET">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2017/10/12">
            <meta name="prism.volume" content="6">
            <meta name="prism.number" content="1830">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.11603.1">
            <meta name="prism.url" content="https://f1000research.com/articles/6-1830">
            <meta name="citation_title" content="The emerging role of PET imaging in dementia">
            <meta name="citation_abstract" content="A compelling need in the field of neurodegenerative diseases is the development and validation of biomarkers for early identification and differential diagnosis. The availability of positron emission tomography (PET) neuroimaging tools for the assessment of molecular biology and neuropathology has opened new venues in the diagnostic design and the conduction of new clinical trials. PET techniques, allowing the in vivo assessment of brain function and pathology changes, are increasingly showing great potential in supporting clinical diagnosis also in the early and even preclinical phases of dementia. This review will summarize the most recent evidence on fluorine-18 fluorodeoxyglucose-, amyloid -, tau -, and neuroinflammation - PET tools, highlighting strengths and limitations and possible new perspectives in research and clinical applications. Appropriate use of PET tools is crucial for a prompt diagnosis and target evaluation of new developed drugs aimed at slowing or preventing dementia.">
            <meta name="citation_description" content="A compelling need in the field of neurodegenerative diseases is the development and validation of biomarkers for early identification and differential diagnosis. The availability of positron emission tomography (PET) neuroimaging tools for the assessment of molecular biology and neuropathology has opened new venues in the diagnostic design and the conduction of new clinical trials. PET techniques, allowing the in vivo assessment of brain function and pathology changes, are increasingly showing great potential in supporting clinical diagnosis also in the early and even preclinical phases of dementia. This review will summarize the most recent evidence on fluorine-18 fluorodeoxyglucose-, amyloid -, tau -, and neuroinflammation - PET tools, highlighting strengths and limitations and possible new perspectives in research and clinical applications. Appropriate use of PET tools is crucial for a prompt diagnosis and target evaluation of new developed drugs aimed at slowing or preventing dementia.">
            <meta name="citation_keywords" content="fluorodeoxyglucose, amyloid, tau, neuroinflammation, molecular imaging, diagnosis, prognosis, biomarker, dementia, PET">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Leonardo Iaccarino">
            <meta name="citation_author_institution" content="In Vivo Human Molecular and Structural Neuroimaging Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy">
            <meta name="citation_author_institution" content="Vita-Salute San Raffaele University, Milan, Italy">
            <meta name="citation_author" content="Arianna Sala">
            <meta name="citation_author_institution" content="In Vivo Human Molecular and Structural Neuroimaging Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy">
            <meta name="citation_author_institution" content="Vita-Salute San Raffaele University, Milan, Italy">
            <meta name="citation_author" content="Silvia Paola Caminiti">
            <meta name="citation_author_institution" content="In Vivo Human Molecular and Structural Neuroimaging Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy">
            <meta name="citation_author_institution" content="Vita-Salute San Raffaele University, Milan, Italy">
            <meta name="citation_author" content="Daniela Perani">
            <meta name="citation_author_institution" content="In Vivo Human Molecular and Structural Neuroimaging Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy">
            <meta name="citation_author_institution" content="Vita-Salute San Raffaele University, Milan, Italy">
            <meta name="citation_author_institution" content="Nuclear Medicine Unit, IRCCS San Raffaele Hospital, Milan, Italy">
            <meta name="citation_publication_date" content="2017/10/12">
            <meta name="citation_volume" content="6">
            <meta name="citation_publication_number" content="1830">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.11603.1">
            <meta name="citation_firstpage" content="1830">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/6-1830/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/6-1830.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=12533 /> <input type=hidden id=articleId name=articleId value=11603 /> <input type=hidden id=xmlUrl value="/articles/6-1830/v1/xml"/> <input type=hidden id=xmlFileName value="-6-1830-v1.xml"> <input type=hidden id=article_uuid value=2ed98459-8c61-4222-8ac2-363a8291901a /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="The emerging role of PET imaging in dementia"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.11603.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.11603.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/6-1830"
  },
  "headline": "The emerging role of PET imaging in dementia",
  "datePublished": "2017-10-12T14:28:49",
  "dateModified": "2017-10-12T14:28:49",
  "author": [
    {
      "@type": "Person",
      "name": "Leonardo Iaccarino"
    },    {
      "@type": "Person",
      "name": "Arianna Sala"
    },    {
      "@type": "Person",
      "name": "Silvia Paola Caminiti"
    },    {
      "@type": "Person",
      "name": "Daniela Perani"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "A compelling need in the field of neurodegenerative diseases is the development and validation of biomarkers for early identification and differential diagnosis. The availability of positron emission tomography (PET) neuroimaging tools for the assessment of molecular biology and neuropathology has opened new venues in the diagnostic design and the conduction of new clinical trials. PET techniques, allowing the in vivo assessment of brain function and pathology changes, are increasingly showing great potential in supporting clinical diagnosis also in the early and even preclinical phases of dementia. This review will summarize the most recent evidence on fluorine-18 fluorodeoxyglucose-, amyloid -, tau -, and neuroinflammation - PET tools, highlighting strengths and limitations and possible new perspectives in research and clinical applications. Appropriate use of PET tools is crucial for a prompt diagnosis and target evaluation of new developed drugs aimed at slowing or preventing dementia."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/6-1830.html",
            "name": "The emerging role of PET imaging in dementia"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> The emerging role of PET imaging in dementia </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=12533 data-id=11603 data-downloads="" data-views="" data-scholar="10.12688/f1000research.11603.1" data-recommended="" data-doi="10.12688/f1000research.11603.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/6-1830/v1/pdf?article_uuid=2ed98459-8c61-4222-8ac2-363a8291901a" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-11603-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-11603-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-11603-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Iaccarino L, Sala A, Caminiti SP and Perani D. The emerging role of PET imaging in dementia [version 1; peer review: 3 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1830 (<a class=new-orange href="https://doi.org/10.12688/f1000research.11603.1" target=_blank>https://doi.org/10.12688/f1000research.11603.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-11603-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=11603 id=track-article-signin-11603 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/11603?target=/articles/6-1830.html">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=12533 /> <input name=articleId type=hidden value=11603 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>The emerging role of PET imaging in dementia</h1><span class=other-info> [version 1; peer review: 3 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Leonardo Iaccarino<sup>1,2</sup>,&nbsp;</span><span class="">Arianna Sala<sup>1,2</sup>,&nbsp;</span><span class="">Silvia Paola Caminiti<sup>1,2</sup>,&nbsp;</span><span class=""><a href="mailto:perani.daniela@hsr.it" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Daniela Perani</span></a><a href="https://orcid.org/0000-0002-9784-292X" target=_blank id=author-orcid-3><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-3><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-9784-292X</div><sup>1-3</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Leonardo Iaccarino<sup>1,2</sup>,&nbsp;</span><span class="">Arianna Sala<sup>1,2</sup>,&nbsp;</span><span class="">Silvia Paola Caminiti<sup>1,2</sup>,&nbsp;</span><span class=""><a href="mailto:perani.daniela@hsr.it" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Daniela Perani</span></a><a href="http://orcid.org/0000-0002-9784-292X" target=_blank id=mauthor-orcid-3><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-3><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-9784-292X</div><sup>1-3</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 12 Oct 2017 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.11603.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Vita-Salute San Raffaele University, Milan, Italy<br/> <sup>2</sup> In Vivo Human Molecular and Structural Neuroimaging Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy<br/> <sup>3</sup> Nuclear Medicine Unit, IRCCS San Raffaele Hospital, Milan, Italy<br/> <p> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=26793-26698></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=26792-26697></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=8696-26699></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> A compelling need in the field of neurodegenerative diseases is the development and validation of biomarkers for early identification and differential diagnosis. The availability of positron emission tomography (PET) neuroimaging tools for the assessment of molecular biology and neuropathology has opened new venues in the diagnostic design and the conduction of new clinical trials. PET techniques, allowing the in vivo assessment of brain function and pathology changes, are increasingly showing great potential in supporting clinical diagnosis also in the early and even preclinical phases of dementia. This review will summarize the most recent evidence on fluorine-18 fluorodeoxyglucose-, amyloid -, tau -, and neuroinflammation - PET tools, highlighting strengths and limitations and possible new perspectives in research and clinical applications. Appropriate use of PET tools is crucial for a prompt diagnosis and target evaluation of new developed drugs aimed at slowing or preventing dementia. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> fluorodeoxyglucose, amyloid, tau, neuroinflammation, molecular imaging, diagnosis, prognosis, biomarker, dementia, PET </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Daniela Perani (<a href="mailto:perani.daniela@hsr.it">perani.daniela@hsr.it</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Daniela Perani </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> The authors declare that they have no competing interests. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2017 Iaccarino L <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Iaccarino L, Sala A, Caminiti SP and Perani D. The emerging role of PET imaging in dementia [version 1; peer review: 3 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1830 (<a href="https://doi.org/10.12688/f1000research.11603.1" target=_blank>https://doi.org/10.12688/f1000research.11603.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 12 Oct 2017, <b>6</b>(F1000 Faculty Rev):1830 (<a href="https://doi.org/10.12688/f1000research.11603.1" target=_blank>https://doi.org/10.12688/f1000research.11603.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 12 Oct 2017, <b>6</b>(F1000 Faculty Rev):1830 (<a href="https://doi.org/10.12688/f1000research.11603.1" target=_blank>https://doi.org/10.12688/f1000research.11603.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d2753e217>Introduction</h2><p class="" id=d2753e220>The last decades have progressively witnessed a shift from a solely clinical diagnosis to a biomarker-supported diagnosis, and molecular neuroimaging techniques such as positron emission tomography (PET) have played a leading role in the dementia diagnostic work-up<sup><a href="#ref-1">1</a>–<a href="#ref-8">8</a></sup>. PET techniques have provided major advances, promoting novel approaches to support an early and differential dementia diagnosis. An accurate quantification, together with <i>ad hoc</i> PET techniques, can nowadays detect very subtle, but significant, pathological and functional neuronal changes, even before clinical symptoms arise. This is crucial for early interventions, personalized care planning, and inclusion in clinical trials<sup><a href="#ref-9">9</a></sup>. Of note, several studies have demonstrated that PET techniques fully show their diagnostic and prognostic value especially when appropriate quantification methods are applied<sup><a href="#ref-10">10</a>–<a href="#ref-13">13</a></sup>. These cardinal issues include timing and protocol of acquisition, parametric modelling and estimation, and the critical definition of the reference region to be used for semi-quantification.</p><p class="" id=d2753e244>Here, we review the most recent advances, strengths, and weaknesses of four of the leading or novel PET tools (or both) in the dementia research field, namely <sup>18</sup>F-FDG (fluorine-18 fluorodeoxyglucose), amyloid, tau, and neuroinflammation PET imaging. The progressive implementation of these techniques, together with the standardization of appropriate methodologies, will allow unique breakthroughs in our understanding of neurodegeneration and will have remarkable implications for diagnostic algorithms and therapy monitoring.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d2753e253><sup>18</sup>F-fluorodeoxyglucose PET</h2><p class="" id=d2753e258>The fundamentals of <sup>18</sup>F-FDG PET are well established and are based on extensively explored molecular mechanisms<sup><a href="#ref-9">9</a></sup>. <sup>18</sup>F-FDG PET signal reflects astrocyte/neuron coupled energy consumption<sup><a href="#ref-14">14</a>–<a href="#ref-17">17</a></sup>, and pioneering and recent studies support the notion that astrocytes play a central role in neuronal glucose consumption<sup><a href="#ref-18">18</a></sup>. Decrease of <sup>18</sup>F-FDG PET uptake is considered to be a direct index of synaptic dysfunction, which can result from a variety of neuropathological events, including but not limited to altered intracellular signaling cascades and mitochondria bioenergetics, impaired neurotransmitter release, and accumulation of neurotoxic protein species<sup><a href="#ref-9">9</a>,<a href="#ref-19">19</a></sup>. Of note, <sup>18</sup>F-FDG PET has been shown to be extremely sensitive to any perturbation in glucose metabolism, being able to capture neurodegeneration not only due to local pathological and biochemical alterations but also due to long-distance functional deafferentations<sup><a href="#ref-9">9</a></sup>.</p><p class="" id=d2753e300>With regard to neurodegenerative diseases, a large and growing body of research has provided convincing and consistent evidence for highly specific patterns of <sup>18</sup>F-FDG PET hypometabolism in distinct dementia conditions<sup><a href="#ref-9">9</a>,<a href="#ref-20">20</a>–<a href="#ref-26">26</a></sup>, even before manifest brain atrophy occurs<sup><a href="#ref-27">27</a>,<a href="#ref-28">28</a></sup>. <sup>18</sup>F-FDG PET can provide support to differential diagnosis based on disease-specific hypometabolism patterns<sup><a href="#ref-20">20</a>,<a href="#ref-23">23</a>,<a href="#ref-25">25</a>,<a href="#ref-26">26</a>,<a href="#ref-29">29</a>,<a href="#ref-30">30</a></sup>. The ability of <sup>18</sup>F-FDG PET to capture disease-specific patterns led to the inclusion of <sup>18</sup>F-FDG PET hypometabolism as a supportive feature in the clinical/research diagnostic criteria of multiple dementia conditions<sup><a href="#ref-1">1</a>–<a href="#ref-6">6</a>,<a href="#ref-8">8</a></sup>. <sup>18</sup>F-FDG PET is an accurate tool for early detection and estimation of increased risk for future dementia conversion<sup><a href="#ref-31">31</a></sup> in the earliest clinical phases of disease, such as in subjects with mild cognitive impairment (MCI), as well as in preclinical cases (asymptomatic subjects at risk or asymptomatic carriers of pathogenetic mutations)<sup><a href="#ref-25">25</a>,<a href="#ref-32">32</a>,<a href="#ref-33">33</a></sup>, providing highly relevant prognostic information for clinical use<sup><a href="#ref-34">34</a></sup>. Crucially, the ability of <sup>18</sup>F-FDG PET to identify heterogeneous hypometabolism patterns in MCI allows clinicians to predict conversion not only to Alzheimer’s disease (AD) dementia but also to non-AD dementia, avoiding multiple additional examinations and unnecessary delay in proper clinical management<sup><a href="#ref-25">25</a>,<a href="#ref-32">32</a></sup>. Given its high predictive value, <sup>18</sup>F-FDG PET will likely play a relevant role for patient inclusion in future clinical trials as an accurate tool to select patients at higher risk for short-term conversion to dementia<sup><a href="#ref-34">34</a></sup>.</p><p class="" id=d2753e401>Notably, domain-specific cognitive deficits are known to be associated with network-specific functional alterations, which can be readily detected by <sup>18</sup>F-FDG PET<sup><a href="#ref-35">35</a></sup>. The close relationship between <sup>18</sup>F-FDG PET and cognitive dysfunctions qualifies this tool as being relevant in the evaluation of treatment outcomes in patients with dementia<sup><a href="#ref-36">36</a>–<a href="#ref-41">41</a></sup>. Considering all of the above, we strongly recommend the introduction of <sup>18</sup>F-FDG PET in future clinical trials, also for the evaluation of therapy outcomes.</p><p class="" id=d2753e424>To date, a number of international workgroups and consortia have advocated for the relevance of <sup>18</sup>F-FDG PET in the diagnostic work-up of neurodegenerative diseases<sup><a href="#ref-1">1</a>–<a href="#ref-6">6</a>,<a href="#ref-8">8</a>,<a href="#ref-34">34</a></sup>. Nevertheless, a recent Cochrane review concluded that there is not enough evidence supporting the routine clinical use of <sup>18</sup>F-FDG PET in the diagnosis of dementia in the prodromal phase<sup><a href="#ref-42">42</a></sup>. This outcome was likely the consequence of the great methodological heterogeneity across <sup>18</sup>F-FDG PET literature, including study design, clinical cohorts, and, crucially, data analysis procedures, which are likely to considerably influence <sup>18</sup>F-FDG PET accuracy, as remarked by a reply from the European Association of Nuclear Medicine<sup><a href="#ref-43">43</a></sup>.</p><p class="" id=d2753e462>The choice of appropriate and validated procedures remains a cardinal issue in <sup>18</sup>F-FDG PET data analysis. As for clinical diagnostic purposes, various quantitative and semi-quantitative approaches have been developed for single-subject analysis (such as statistical parametric mapping (SPM)<sup><a href="#ref-44">44</a></sup> and Neurostat<sup><a href="#ref-45">45</a>–<a href="#ref-47">47</a></sup>)<sup><a href="#ref-12">12</a></sup>. SPM is one of the most diffuse methods to statistically analyze voxel-wise <sup>18</sup>F-FDG PET data<sup><a href="#ref-34">34</a></sup> and its accuracy has been validated in clinical research settings<sup><a href="#ref-25">25</a>,<a href="#ref-26">26</a>,<a href="#ref-30">30</a>,<a href="#ref-33">33</a></sup>. A recently developed and validated single-subject SPM procedure takes advantage of an optimized spatial normalization, based on a custom <sup>18</sup>F-FDG-PET dementia-specific template, and of a high statistical accuracy of the resulting SPM t-maps, based on a large normal dataset for comparisons at the single-subject level<sup><a href="#ref-30">30</a>,<a href="#ref-48">48</a></sup>. This <sup>18</sup>F-FDG-PET SPM procedure allows the identification of disease-specific brain hypometabolism patterns in single cases, and in cross-validation studies for diagnostic accuracy it performs better than visual qualitative assessment of <sup>18</sup>F-FDG-PET uptake images, clinical assessment of patients, cerebrospinal fluid biomarkers, and amyloid PET<sup><a href="#ref-25">25</a>,<a href="#ref-33">33</a></sup>. This method has been validated in clinical research settings both for differential dementia diagnosis<sup><a href="#ref-23">23</a>,<a href="#ref-25">25</a>,<a href="#ref-26">26</a>,<a href="#ref-30">30</a></sup>, including atypical parkinsonisms<sup><a href="#ref-26">26</a></sup>, and for prognosis in prodromal cases<sup><a href="#ref-25">25</a>,<a href="#ref-30">30</a>,<a href="#ref-32">32</a>,<a href="#ref-33">33</a></sup>. We strongly support the implementation of this method not only in academic research but also in routine clinical settings. Other <i>in vivo</i> neuroimaging or cerebrospinal fluid biomarkers may also be added in the diagnostic work-up of cases with unclear <sup>18</sup>F-FDG-PET hypometabolism patterns, likely providing further support to dementia diagnosis.</p><p class="" id=d2753e564>In the last few years, neurodegenerative conditions have been progressively conceived as diseases of neural networks, which led to the development of multiple statistical multi-variate approaches able to capture their large-scale biological complexity<sup><a href="#ref-49">49</a>,<a href="#ref-50">50</a></sup>. <sup>18</sup>F-FDG PET has been successfully used as a proxy to evaluate metabolic connectivity, assuming that regions whose metabolism is correlated are functionally interconnected<sup><a href="#ref-51">51</a></sup>. Of note, distinct patterns of connectivity alterations are associated with different neurodegenerative conditions<sup><a href="#ref-52">52</a></sup>. A reduced metabolic connectivity in the hippocampi and in the dorsolateral prefrontal cortex networks was reported in AD<sup><a href="#ref-53">53</a></sup>, with an intermediate level of impairment found in MCI<sup><a href="#ref-54">54</a></sup>. In contrast, a study on dementia with Lewy bodies (DLB) found altered metabolic connectivity in the occipital cortex, cerebellum, thalamus, and brain stem<sup><a href="#ref-55">55</a></sup>. In Parkinson’s disease (PD), an extensive decrease of connectivity in frontal regions, brain stem, and cerebellum was present<sup><a href="#ref-56">56</a></sup>. Though compelling, the net majority of these findings are based on group-level analysis, and therefore the single-subject diagnostic value of metabolic connectivity approaches remains to be determined.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d2753e605>Amyloid PET</h2><p class="" id=d2753e608>The first developed tracer for amyloid imaging was the <sup>18</sup>F-FDDNP, eventually discarded for its affinity to both amyloid and tau<sup><a href="#ref-57">57</a></sup>. Later, the “Pittsburgh compound B” (<sup>11</sup>C-PiB) was developed, despite the limitation of the carbon-11 short half-life, requiring an on-site cyclotron and limiting its use in clinical settings. Since 2012, <sup>18</sup>F-labelled amyloid radiotracers with longer half-life entered clinical and research evaluation in AD (<sup>18</sup>F-florbetapir, <sup>18</sup>F-florbetaben, and <sup>18</sup>F-flutemetamol)<sup><a href="#ref-58">58</a></sup>. Since cortical retention for each <sup>18</sup>F ligand is highly correlated among tracers<sup><a href="#ref-59">59</a></sup>, amyloid-PET data obtained from different tracers may also be compared provided that standardized acquisition procedures<sup><a href="#ref-60">60</a></sup> and specific methods of analysis, such as the recently proposed Centiloid method<sup><a href="#ref-61">61</a></sup>, are adopted. Standardization of acquisition procedures and data analysis will certainly improve the incorporation of amyloid-PET biomarkers into the standard diagnostic criteria for AD<sup><a href="#ref-3">3</a>,<a href="#ref-5">5</a>,<a href="#ref-7">7</a></sup>. Both <sup>11</sup>C-PiB and <sup>18</sup>F-labelled amyloid-PET tracers bind with high affinity to fibrillar amyloid in neuritic plaques<sup><a href="#ref-62">62</a>–<a href="#ref-65">65</a></sup>. However, diffuse plaques with low fibrillarity and cerebral amyloid angiopathy (CAA) also contribute to part of tracer binding<sup><a href="#ref-66">66</a></sup>.</p><p class="" id=d2753e681>The large amount of scientific evidence obtained by <i>in vivo</i> imaging of brain amyloid burden has challenged the primary role for amyloid in AD pathogenesis<sup><a href="#ref-67">67</a>,<a href="#ref-68">68</a></sup>. Still, appropriate use criteria for amyloid-PET imaging stress the high accuracy of amyloid PET in ruling out AD<sup><a href="#ref-69">69</a></sup> and in supporting AD dementia diagnosis, especially in three main clinical populations: (i) subjects with MCI, (ii) patients with suspected AD but atypical presentation or etiologically mixed presentation, and (iii) patients with early-onset dementia<sup><a href="#ref-70">70</a>,<a href="#ref-71">71</a></sup>. Of note, in MCI, recent studies have shown that risk to convert to AD is greater in amyloid-positive subjects<sup><a href="#ref-72">72</a></sup> and that the time of conversion from MCI to AD dementia negatively correlates with the annual increase in amyloid deposition rate<sup><a href="#ref-73">73</a></sup>. However, since amyloid deposition rate increases rapidly in the prodromal phases of the disease<sup><a href="#ref-74">74</a></sup>, in some subjects it might have already reached a plateau in the MCI stage<sup><a href="#ref-22">22</a></sup>. For this reason, it has recently been suggested that amyloid rate might not be the best predictor of time to conversion from MCI to AD dementia as compared with neuronal injury biomarkers such as <sup>18</sup>F-FDG PET<sup><a href="#ref-22">22</a></sup>. It should be taken into account that the characteristics of <sup>18</sup>F-FDG-PET hypometabolic patterns in MCI individuals can indicate the prognostic risk of progression to different dementia conditions (see above)<sup><a href="#ref-23">23</a>–<a href="#ref-25">25</a>,<a href="#ref-32">32</a></sup>. In addition, amyloid-PET studies showed MCI patients presenting with wide variations in amyloid burden load<sup><a href="#ref-75">75</a>–<a href="#ref-77">77</a></sup>, sometimes showing an intermediate “gray area” burden, challenging attempts to classify it as either positive or negative<sup><a href="#ref-78">78</a></sup>.</p><p class="" id=d2753e754>In patients with dementia, amyloid PET is recognized as a powerful tool to differentiate conditions characterized by a prominent amyloid deposition (that is, dementia due to AD) from those without, such as frontotemporal dementia (FTD)<sup><a href="#ref-79">79</a></sup>. Recently, a comprehensive meta-analysis indicated that accuracy of amyloid PET in differential diagnosis of dementia might actually be circumscribed to relatively young demented patients since amyloid positivity dramatically increases with age in cognitively normal individuals (high prevalence after 70 years of age) and in non-AD dementia<sup><a href="#ref-80">80</a>,<a href="#ref-81">81</a></sup>. Furthermore, amyloid PET cannot distinguish specific AD syndromes<sup><a href="#ref-82">82</a>,<a href="#ref-83">83</a></sup> and other pathologies characterized by amyloidosis, such as DLB and CAA, and most studies show a non-specific pattern of amyloid burden diffusely distributed throughout the entire cortex across diseases<sup><a href="#ref-84">84</a>–<a href="#ref-86">86</a></sup>. Of note, in CAA, <sup>11</sup>C-PiB was consistently shown to bind to cerebrovascular amyloid plaques, especially in the occipital cortex<sup><a href="#ref-66">66</a>,<a href="#ref-87">87</a></sup>. As a consequence, amyloid tracers should be regarded as a general marker of brain amyloidosis and not of specific AD amyloidosis<sup><a href="#ref-12">12</a>,<a href="#ref-66">66</a></sup>.</p><p class="" id=d2753e800>As for amyloid positivity in normal aging, it is currently debated whether cognitively normal subjects with a positive amyloid-PET scan represent prodromal AD cases who will eventually develop AD dementia or rather will remain stable<sup><a href="#ref-9">9</a>,<a href="#ref-67">67</a>,<a href="#ref-78">78</a>,<a href="#ref-88">88</a></sup>. Since variations in amyloid deposition rate in normal individuals are subtle (that is, 2–5%)<sup><a href="#ref-89">89</a></sup>, a long follow-up might be necessary to observe development of dementia, and up to 19 years might be needed to reach the mean value of amyloid observed in AD<sup><a href="#ref-90">90</a></sup>. However, the view that amyloid positivity equals AD dementia diagnosis has been challenged by the high prevalence of amyloid positivity in the elderly (about 44% in nonagenarians) despite normal cognitive function<sup><a href="#ref-80">80</a></sup>. Of note, the classification of amyloid-positive or -negative is dependent on the cutoff selected for positivity<sup><a href="#ref-78">78</a></sup>, which varies according to the quantification method adopted for tracer binding estimation. In this regard, different quantification methods for amyloid PET have been proposed, including either compartmental model binding tools or reference tissue model-based tools, and various regions of interests are suggested for the latter (for instance,<sup><a href="#ref-91">91</a></sup>). A critical issue in amyloid-PET data analysis relates to the definition of the optimal reference region for semi-quantification. Most of the amyloid-PET studies tend to consider the cerebellum, as either a whole or gray matter only, as an optimal reference region, but the pons has been suggested as well<sup><a href="#ref-92">92</a></sup>. Particular caution is needed in the case of longitudinal evaluation of amyloid-PET changes, where a direct standardized uptake value ratio (SUVR) semi-quantification could be sensitive to flow changes and produce biased results<sup><a href="#ref-91">91</a></sup>. In longitudinal studies, the inclusion of a supratentorial white matter region should be considered for a robust reference<sup><a href="#ref-93">93</a></sup>. It is generally accepted that compartmental models provide the most accurate results, and, for routine scans, a simplified reference tissue can be used<sup><a href="#ref-94">94</a>,<a href="#ref-95">95</a></sup>. Still, no specific guidelines for amyloid PET have been established yet<sup><a href="#ref-91">91</a></sup>. Identification of an optimal normal versus abnormal cutoff with amyloid PET is also crucial in patient selection and inclusion in clinical trials.</p><p class="" id=d2753e861>Currently, amyloid PET imaging is a crucial requirement for inclusion/exclusion in clinical trials. The majority of clinical trials in AD have focused on amyloid therapies (for example, see references <a href="#ref-96">96</a>–<a href="#ref-98">98</a>), also including serial amyloid-PET scans to evaluate decreases in cerebral amyloid burden<sup><a href="#ref-97">97</a>,<a href="#ref-98">98</a></sup>. An open question remains as to which amyloid-PET tracers are the most adequate to evaluate the efficacy of therapeutic interventions. Crucially, the adoption of amyloid-PET imaging for clinical trials has been criticized because currently available amyloid PET tracers measure fibrillary insoluble amyloid burden and are insensitive to toxic soluble amyloid oligomers<sup><a href="#ref-99">99</a></sup>, which are much more clinically relevant<sup><a href="#ref-100">100</a></sup>. From the methodological standpoint, clinical trials may suffer from the lack of appropriate quantification, usually limited to SUVR semi-quantification (for example, see references <a href="#ref-96">96</a>–<a href="#ref-98">98</a>). Furthermore, the lack of a strong association between amyloid burden and measures of cognition and neurodegeneration<sup><a href="#ref-68">68</a></sup>, as shown by several multi-tracer PET studies<sup><a href="#ref-82">82</a>,<a href="#ref-83">83</a>,<a href="#ref-101">101</a>–<a href="#ref-104">104</a></sup>, suggests that clinical trials should include other pathological and topographical neurodegeneration biomarkers.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d2753e912>Tau PET</h2><p class="" id=d2753e915>One of the most recent advances for <i>in vivo</i> PET imaging is the evaluation of cerebral tau burden<sup><a href="#ref-105">105</a>–<a href="#ref-108">108</a></sup>. Tau protein is physiologically associated with the stabilization, assembly, and functional integrity of microtubules, critical structures for cytoskeletal support and intracellular molecular transport<sup><a href="#ref-109">109</a>,<a href="#ref-110">110</a></sup>. Its hyperphosphorylation and accumulation are key pathogenic events in a number of neurodegenerative conditions (that is, tauopathies) and can potentially trigger remarkably different clinical phenotypes and disease courses<sup><a href="#ref-109">109</a>,<a href="#ref-111">111</a></sup>. Tau protein can present in six different isoforms, which are grouped on the basis of the number of microtubule-binding domain repeats (that is, three or four (3R/4R))<sup><a href="#ref-110">110</a></sup>. In a normal brain, the ratio of 3R/4R tau is 1:1, but it can change across the different pathologies, such as in the case of progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD), which are 4R-dominant, or in the case of Pick’s disease, which is 3R-dominant<sup><a href="#ref-108">108</a>,<a href="#ref-109">109</a></sup>. When agglomerating, hyperphosphorylated tau can additionally assume different conformations, such as paired helical filaments (PHFs), straight filaments, and irregular filaments<sup><a href="#ref-109">109</a></sup>. This biological complexity implies a considerably heterogeneous pathological picture which historically hampered the development of selective tau radioligands suitable for <i>in vivo</i> PET imaging<sup><a href="#ref-106">106</a></sup>.</p><p class="" id=d2753e965>Notwithstanding tau biological complexity, the synthesis of some radioligands is now available and is rapidly entering into extensive research use and possibly for a potential validation in clinical practice<sup><a href="#ref-108">108</a></sup>. To date, three broad groups of radioligands are under extensive evaluation: the <sup>18</sup>F-THK5351, <sup>18</sup>F-THK5117, or <sup>18</sup>F-THK5105<sup><a href="#ref-112">112</a>–<a href="#ref-114">114</a></sup>; the <sup>18</sup>F-T807 (also known as <sup>18</sup>F-AV1451 or <sup>18</sup>F-Flortaucipir)<sup><a href="#ref-115">115</a></sup>; and the <sup>11</sup>C-PBB3<sup><a href="#ref-116">116</a></sup>.</p><p class="" id=d2753e1009>The first tau PET imaging results in the AD spectrum have provided compelling evidence for a tight relationship between tau burden and synaptic dysfunction, gray matter atrophy, and cognitive deficits<sup><a href="#ref-117">117</a>–<a href="#ref-120">120</a></sup>, confirming previous post-mortem evidence<sup><a href="#ref-121">121</a>,<a href="#ref-122">122</a></sup>. Early reports additionally suggested that tau PET was able to recapitulate the neuropathological Braak staging, suggesting that it could be a valuable tool for the <i>in vivo</i> staging of AD pathology progression<sup><a href="#ref-120">120</a>,<a href="#ref-123">123</a></sup>. Multiple reports showed a cross-sectional association between worsening of cognitive impairment and increasing cortical tau-PET binding, from normal cognition to MCI and AD dementia stages<sup><a href="#ref-117">117</a>,<a href="#ref-118">118</a>,<a href="#ref-120">120</a></sup>. Of note, the correspondence between tau accumulation, neurodegeneration, and clinical manifestations stands in stark contrast with amyloid-PET evidence, which is not associated with specific patterns of neurodegeneration or cognitive impairment (see “Amyloid PET” section above). The topographical specificity of tau-PET uptake distribution especially emerged for the AD variants, such as posterior cortical atrophy and the logopenic variant of primary progressive aphasia, which are known to be associated with phenotype-specific patterns of neurodegeneration and cognitive deficits<sup><a href="#ref-124">124</a></sup>. These studies showed a consistent spatial correspondence between <i>in vivo</i> tau burden, neurodegeneration, and clinical syndromes, at group and single-subject levels<sup><a href="#ref-83">83</a>,<a href="#ref-119">119</a>,<a href="#ref-125">125</a>–<a href="#ref-127">127</a></sup>.</p><p class="" id=d2753e1067>The introduction of tau-PET techniques is reshaping the AD research field, allowing a more targeted evaluation of the original amyloid cascade hypothesis, which remains highly controversial (see “Amyloid PET” section above and<sup><a href="#ref-67">67</a>,<a href="#ref-128">128</a></sup>). Several studies specifically focused on the relationships between tau and amyloid accumulation in AD and in healthy aging<sup><a href="#ref-119">119</a>,<a href="#ref-120">120</a>,<a href="#ref-129">129</a>–<a href="#ref-133">133</a></sup>. The most consistent and compelling observation regards the variable patterns of tau deposition in subjects with or without a considerable cerebral amyloid burden<sup><a href="#ref-108">108</a></sup>. Medial temporal lobe (MTL) tau accumulation has been associated with an age-related process independent from amyloid burden<sup><a href="#ref-133">133</a></sup>, whereas tau spreading outside the MTL is almost invariantly associated with an amyloid-positive status<sup><a href="#ref-132">132</a>–<a href="#ref-135">135</a></sup>.</p><p class="" id=d2753e1106>While providing a wealth of evidence with critical implications for disease tracking and monitoring of AD interventions, the above-mentioned studies have also highlighted several areas of criticisms which are in need of further consideration<sup><a href="#ref-136">136</a></sup>. Of note, the selectivity of the current tau-PET radioligands for non-AD tauopathies is not well understood. Previous autoradiographical studies on the most commonly adopted tau-PET compounds, such as the <sup>18</sup>F-AV1451, have shown high affinity for the AD tauopathy (that is, for intracellular neurofibrillary tangles composed of PHFs, with an equal 3R/4R tau ratio)<sup><a href="#ref-137">137</a>,<a href="#ref-138">138</a></sup>. The same, however, was not observed for the 4R tau aggregates typical of primary tauopathies, such as PSP or CBD, where post-mortem results are more heterogeneous and overall present less robust staining<sup><a href="#ref-137">137</a>–<a href="#ref-142">142</a></sup>. Another area of concern regards consistent non-specific tau-PET binding in subcortical structures, especially in the striatum and in the choroid plexus, in healthy controls, suggesting that the currently available tau tracers could present off-target binding, such as to neuromelanin<sup><a href="#ref-137">137</a>,<a href="#ref-138">138</a></sup>. The possibility that tau-PET ligands present non-specific binding is supported by a recent study showing that selegiline, a monoamine oxidase-B (MAO-B) inhibitor, significantly reduces brain <sup>18</sup>F-THK5351 uptake<sup><a href="#ref-143">143</a></sup>. Additionally, it has been suggested that AV1451 could present non-specific binding to MAO-A as well<sup><a href="#ref-144">144</a></sup>, even if there are opposite results<sup><a href="#ref-145">145</a></sup>. Another issue in tau-PET quantification is represented by the time window adopted for SUVR semi-quantification. As for <sup>18</sup>F-AV1451, the 80- to 100-minute SUVR, commonly adopted in previous research studies<sup><a href="#ref-136">136</a></sup>, might be not optimal given the evidence for a further 30% increase of SUVR values up to 180 minutes from injection<sup><a href="#ref-146">146</a></sup>. The longer uptake time window of this tracer should be taken into account when such semi-quantifications are adopted<sup><a href="#ref-146">146</a></sup>. Given these premises, tau-PET diagnostic value in AD, and especially in non-AD tauopathies, is in need of further evaluation.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d2753e1172>Neuroinflammation PET</h2><p class="" id=d2753e1175><i>In vivo</i> imaging of neuroinflammation responses has recently gained particular interest in clinical neuroscience research<sup><a href="#ref-147">147</a>,<a href="#ref-148">148</a></sup>, and neuroinflammation has been recognized as a key player in the course of neurodegeneration<sup><a href="#ref-149">149</a></sup>. The currently available PET molecular imaging techniques allow the measurement of neuroinflammation through imaging of both astrocytes and microglia activation<sup><a href="#ref-147">147</a></sup>. Astrocytosis can be uniquely measured through PET and the <sup>11</sup>C-deuterium-L-deprenyl ligand (<sup>11</sup>C-DED), which is an irreversible inhibitor of the MAO-B enzyme, over-expressed during astrocyte activation<sup><a href="#ref-150">150</a></sup>.</p><p class="" id=d2753e1206>The great majority of research has otherwise focused on PET imaging of microglia activation, and many radioligands have been synthetized, the great majority of which target the over-expression of the 18-kDa translocator protein (TSPO). TSPO is an outer mitochondrial membrane protein, expressed mostly by microglia and, to a lesser extent, by astrocytes<sup><a href="#ref-151">151</a>,<a href="#ref-152">152</a></sup>. Its levels in the central nervous system in healthy conditions are generally low, whereas their over-expression in the disease state has been well documented<sup><a href="#ref-152">152</a></sup>.</p><p class="" id=d2753e1220>Among the others, <sup>11</sup>C-(R)-PK11195 is the first and prototypical TSPO radioligand<sup><a href="#ref-153">153</a></sup> and has been widely adopted in multiple neurodegenerative conditions<sup><a href="#ref-147">147</a>,<a href="#ref-154">154</a></sup>. A second generation of radioligands has been subsequently introduced, mainly to overcome some of the <sup>11</sup>C-(R)-PK11195 limitations, such as limited availability of <sup>11</sup>C ligands in clinical settings and low signal-to-noise ratio<sup><a href="#ref-155">155</a></sup>. These second-generation ligands come with both <sup>11</sup>C or <sup>18</sup>F isotopes, such as <sup>11</sup>C-PBR28 and <sup>18</sup>F-DPA714, and overall display higher binding affinities<sup><a href="#ref-155">155</a></sup>. A few years ago, however, it was shown that a single-nucleotide polymorphism (that is, rs6971) in the TSPO gene can considerably influence the uptake of the second-generation tracers, making genetic testing mandatory<sup><a href="#ref-156">156</a>,<a href="#ref-157">157</a></sup>. While a third generation of fluorinated radioligands is currently under evaluation<sup><a href="#ref-158">158</a></sup>, the <sup>11</sup>C-(R)-PK11195 remains the best validated and diffusely adopted in human studies, not requiring TSPO genotype evaluation.</p><p class="" id=d2753e1279>Of note, quantification of TSPO PET can be particularly challenging<sup><a href="#ref-159">159</a></sup> given the intrinsic characteristics of the TSPO protein<sup><a href="#ref-159">159</a></sup>. For instance, TSPO can be remarkably expressed in the endothelium, and it is heterogeneously distributed across the brain, hindering the definition of an anatomically defined reference region<sup><a href="#ref-159">159</a></sup>. To overcome the latter limit, several advanced clustering algorithms have been developed to iteratively select groups of voxels sharing specific time activity curves (that is, resembling temporal delivery of the tracer in gray matter without specific binding)<sup><a href="#ref-160">160</a>–<a href="#ref-162">162</a></sup>. The complexity of TSPO-PET quantification and the use of radioligands with different properties, together with the characteristics of TSPO distribution, likely contributed to the pronounced heterogeneity of the reported findings in the literature. A representative example comes from TSPO-PET imaging of AD<sup><a href="#ref-154">154</a>,<a href="#ref-155">155</a>,<a href="#ref-163">163</a></sup>. Previous studies have shown significant microglia activation in key AD signature regions, such as entorhinal and temporo-parietal areas, whereas some have reported negative results<sup><a href="#ref-155">155</a></sup>. As for relation to disease phase, some studies described more significant microgliosis<sup><a href="#ref-164">164</a></sup> and astrogliosis<sup><a href="#ref-165">165</a></sup> in prodromal/preclinical rather than AD dementia phases whereas others showed the opposite<sup><a href="#ref-166">166</a></sup>. Of note, previous <sup>11</sup>C-DED-PET studies have accordingly shown more significant astrocytosis in prodromal and preclinical genetic AD subjects when compared with subjects in later disease phases<sup><a href="#ref-165">165</a>,<a href="#ref-167">167</a></sup>. Diverging evidence also exists regarding the association between microglia activation and amyloid burden<sup><a href="#ref-168">168</a>–<a href="#ref-170">170</a></sup>. Several recent studies have provided novel evidence for longitudinal associations between neuroinflammation, neurodegeneration, and pathology accumulation in AD<sup><a href="#ref-165">165</a>,<a href="#ref-171">171</a>,<a href="#ref-172">172</a></sup>. An increase of microglia activation in AD was longitudinally associated with amyloid accumulation and reductions of brain glucose metabolism<sup><a href="#ref-171">171</a></sup>. Another recent study introduced a possible “two-peaks” model of microglia activation in AD<sup><a href="#ref-172">172</a></sup> with microgliosis first peaking at the prodromal MCI stage, afterwards declining approaching AD dementia transition, and then increasing again during the final disease stages<sup><a href="#ref-172">172</a></sup>. As for <sup>11</sup>C-DED PET, a recent longitudinal study on carriers of autosomal dominant AD mutations also indicated that the highest detected astrocyte activations were present at the asymptomatic stage, progressively decreasing approaching clinical onset<sup><a href="#ref-165">165</a></sup>. Of note, amyloid accumulation followed an opposite trend<sup><a href="#ref-165">165</a></sup>.</p><p class="" id=d2753e1381>As for other neurodegenerative conditions, TSPO PET has been successfully applied in synucleinopathies, such as in DLB, PD, and PD with dementia<sup><a href="#ref-173">173</a>–<a href="#ref-175">175</a></sup>; in FTD<sup><a href="#ref-176">176</a></sup>; in atypical parkinsonisms such as multiple system atrophy (MSA), CBD, and PSP<sup><a href="#ref-177">177</a>–<a href="#ref-179">179</a></sup>; and in prion diseases, such as Creutzfeldt-Jakob disease<sup><a href="#ref-180">180</a></sup>.</p><p class="" id=d2753e1406>Crucially, it remains to be understood whether this local immune response is thoroughly beneficial or rather can promote neurodegeneration<sup><a href="#ref-149">149</a></sup>. This is particularly true in relation to microglia activation, which is a complex and dynamic process<sup><a href="#ref-181">181</a></sup>. Understanding whether and how microglia is reacting within a disease course may provide important insights into disease pathogenesis and have remarkable implications for future clinical trials. PET imaging of neuroinflammation provides the unique chance of evaluating, <i>in vivo</i>, the reactivity of microglia cells, but also astrocytes by means of <sup>11</sup>C-deprenyl PET, to either neuronal damage or pathology accumulation, with remarkable implications for research and possibly future clinical settings<sup><a href="#ref-154">154</a>,<a href="#ref-163">163</a></sup>.</p><p class="" id=d2753e1430>Further validation of TSPO-PET imaging is needed to translate its application to clinical practice. Notwithstanding the broad efforts, the greatest challenge is still represented by the lack of a standardized methodology, which hampers the reproducibility and the biological interpretation of the findings. Additionally, the debate on the actual physiological role of the TSPO protein is yet to be solved<sup><a href="#ref-182">182</a>,<a href="#ref-183">183</a></sup>. One of the most remarkable future applications of neuroinflammation PET is the outcome evaluation of pharmacological interventions. Some studies have already used TSPO PET to monitor the anti-inflammatory or immunomodulatory therapies in PD<sup><a href="#ref-184">184</a></sup>, MSA<sup><a href="#ref-185">185</a></sup>, and multiple sclerosis<sup><a href="#ref-186">186</a>,<a href="#ref-187">187</a></sup>.</p><p class="" id=d2753e1455>Several non-TSPO new targets to measure microglia activation with PET-based techniques, including but not limited to purinergic and cannabinoid receptors, are currently under evaluation<sup><a href="#ref-188">188</a></sup>. The development of these new radioligands not only is linked to the attempt of overcoming TSPO intrinsic limits (see above) but also aims at the detection of specific microglial functional phenotypes<sup><a href="#ref-188">188</a></sup>. In neurodegenerative conditions, microglia can acquire very diverse functional phenotypes based upon several factors<sup><a href="#ref-189">189</a></sup>; in this direction, the development of PET radioligands with particular affinity for specific microglial polarizations (for instance, homeostatic versus neurotoxic) would be of utmost importance. Preliminary data are available for PET imaging of the cannabinoid receptor type 2 (CB2R), which is over-expressed by microglial cells during activation and has been shown to promote neuroprotection<sup><a href="#ref-190">190</a></sup>. The CB2R PET radioligand, <sup>11</sup>C-NE40, has been recently used in patients with AD<sup><a href="#ref-191">191</a></sup>. The development of PET tracers addressing phenotype-specific microglia activation will hopefully allow novel insights into how neuroinflammation responses could be contributing to neurodegeneration.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d2753e1486>Conclusions</h2><p class="" id=d2753e1489>Recent studies have progressively highlighted how the same pathology can trigger very diverse functional phenotypes. Given the recent advances in neuroimaging techniques, it is likely that the multi-modal integration of pathological and functional biomarkers will be the key proxy to the most accurate identification of both underlying pathology and phenotypic syndrome, leading to the tailoring of the most appropriate care plan and prognosis. The increasing availability of PET <i>in vivo</i> pathology markers will likely favor the implementation of a spectrum-based research framework.</p><p class="" id=d2753e1495>Although the clinical usefulness of amyloid PET is recognized, it is particularly recommended to specific clinical sub-populations, such as early and atypical clinical presentations. The novel tau tracers are promising, given their tight relationship with neurodegeneration, but the lack of affinity for different tau isoforms and the evidence for non-specific bindings shown by several of these radioligands call for the development of novel compounds overcoming these limitations. In this context, <sup>18</sup>F-FDG PET provides a well-validated key value to dementia diagnosis and prognosis and should be considered as one of the most valuable tools for monitoring neurodegenerative disease status and progression and also for selecting candidates for clinical trials and evaluating treatment response in both AD and non-AD pathologies.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d2753e1504>Abbreviations</h2><p class="" id=d2753e1507><sup>11</sup>C-DED, <sup>11</sup>C-deuterium-L-deprenyl; <sup>11</sup>C-PiB, carbon-11 Pittsburgh compound B; <sup>18</sup>F-FDG, fluorine-18 fluorodeoxyglucose; AD, Alzheimer’s disease; CAA, cerebral amyloid angiopathy; CB2R, cannabinoid receptor type 2; CBD, corticobasal degeneration; DLB, dementia with Lewy bodies; FTD, frontotemporal dementia; MAO, monoamine oxidase; MCI, mild cognitive impairment; MSA, multiple system atrophy; MTL, medial temporal lobe; PD, Parkinson’s disease; PET, positron emission tomography; PHF, paired helical filament; PSP, progressive supranuclear palsy; SPM, statistical parametric mapping; SUVR, standardized uptake value ratio; TSPO, translocator protein.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d2753e1 class=n-a></a><h2 class=main-title id=d3313>Author contributions</h2><p class=metadata-entry><a name=d2753e147 class=n-a></a><p id=d2753e148> All authors contributed to the preparation of the manuscript and agreed to the final content. DP conceived the study and revised the manuscript.</p></p></div><div class=back-section><a name=d2753e1 class=n-a></a><h2 class=main-title id=d3317>Competing interests</h2><p class=metadata-entry><a name=d2753e151 class=n-a></a><p id=d2753e152> The authors declare that they have no competing interests.</p></p></div><div class=back-section><a name=d2753e1 class=n-a></a><h2 class=main-title id=d3319>Grant information</h2><p>The author(s) declared that no grants were involved in supporting this work.</p></div><div class=back-section><a name=d2753e1525 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d3970>References</h2><div class="section ref-list"><a name=d2753e1525 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d2753e1532 class=n-a></a>Albert MS, DeKosky ST, Dickson D, <i> et al.</i>: The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. <i>Alzheimers Dement.</i> 2011; <b>7</b>(3): 270–9. <a target=xrefwindow id=d2753e1543 href="http://www.ncbi.nlm.nih.gov/pubmed/21514249">PubMed Abstract </a> | <a target=xrefwindow id=d2753e1546 href="http://dx.doi.org/10.1016/j.jalz.2011.03.008">Publisher Full Text </a> | <a target=xrefwindow id=d2753e1550 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3312027">Free Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/9242956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2753e1559 class=n-a></a>Gorno-Tempini ML, Hillis AE, Weintraub S, <i> et al.</i>: Classification of primary progressive aphasia and its variants. <i>Neurology.</i> 2011; <b>76</b>(11): 1006–14. <a target=xrefwindow id=d2753e1570 href="http://www.ncbi.nlm.nih.gov/pubmed/21325651">PubMed Abstract </a> | <a target=xrefwindow id=d2753e1573 href="http://dx.doi.org/10.1212/WNL.0b013e31821103e6">Publisher Full Text </a> | <a target=xrefwindow id=d2753e1577 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3059138">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/9242956">F1000 Recommendation</a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d2753e1590 class=n-a></a>McKhann GM, Knopman DS, Chertkow H, <i> et al.</i>: The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. <i>Alzheimers Dement.</i> 2011; <b>7</b>(3): 263–9. <a target=xrefwindow id=d2753e1601 href="http://www.ncbi.nlm.nih.gov/pubmed/21514250">PubMed Abstract </a> | <a target=xrefwindow id=d2753e1604 href="http://dx.doi.org/10.1016/j.jalz.2011.03.005">Publisher Full Text </a> | <a target=xrefwindow id=d2753e1608 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3312024">Free Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/13328981"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2753e1617 class=n-a></a>Rascovsky K, Hodges JR, Knopman D, <i> et al.</i>: Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. <i>Brain.</i> 2011; <b>134</b>(Pt 9): 2456–77. <a target=xrefwindow id=d2753e1628 href="http://www.ncbi.nlm.nih.gov/pubmed/21810890">PubMed Abstract </a> | <a target=xrefwindow id=d2753e1631 href="http://dx.doi.org/10.1093/brain/awr179">Publisher Full Text </a> | <a target=xrefwindow id=d2753e1635 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3170532">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/13328981">F1000 Recommendation</a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d2753e1648 class=n-a></a>Sperling RA, Aisen PS, Beckett LA, <i> et al.</i>: Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. <i>Alzheimers Dement.</i> 2011; <b>7</b>(3): 280–92. <a target=xrefwindow id=d2753e1659 href="http://www.ncbi.nlm.nih.gov/pubmed/21514248">PubMed Abstract </a> | <a target=xrefwindow id=d2753e1662 href="http://dx.doi.org/10.1016/j.jalz.2011.03.003">Publisher Full Text </a> | <a target=xrefwindow id=d2753e1666 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3220946">Free Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d2753e1676 class=n-a></a>Armstrong MJ, Litvan I, Lang AE, <i> et al.</i>: Criteria for the diagnosis of corticobasal degeneration. <i>Neurology.</i> 2013; <b>80</b>(5): 496–503. <a target=xrefwindow id=d2753e1687 href="http://www.ncbi.nlm.nih.gov/pubmed/23359374">PubMed Abstract </a> | <a target=xrefwindow id=d2753e1690 href="http://dx.doi.org/10.1212/WNL.0b013e31827f0fd1">Publisher Full Text </a> | <a target=xrefwindow id=d2753e1694 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3590050">Free Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718426129"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2753e1703 class=n-a></a>Dubois B, Feldman HH, Jacova C, <i> et al.</i>: Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria. <i>Lancet Neurol.</i> 2014; <b>13</b>(6): 614–29. <a target=xrefwindow id=d2753e1714 href="http://www.ncbi.nlm.nih.gov/pubmed/24849862">PubMed Abstract </a> | <a target=xrefwindow id=d2753e1717 href="http://dx.doi.org/10.1016/S1474-4422(14)70090-0">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718426129">F1000 Recommendation</a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d2753e1730 class=n-a></a>McKeith IG, Dickson DW, Lowe J, <i> et al.</i>: Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. <i>Neurology.</i> 2005; <b>65</b>(12): 1863–72. <a target=xrefwindow id=d2753e1741 href="http://www.ncbi.nlm.nih.gov/pubmed/16237129">PubMed Abstract </a> | <a target=xrefwindow id=d2753e1744 href="http://dx.doi.org/10.1212/01.wnl.0000187889.17253.b1">Publisher Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d2753e1753 class=n-a></a>Perani D: FDG-PET and amyloid-PET imaging: the diverging paths. <i>Curr Opin Neurol.</i> 2014; <b>27</b>(4): 405–13. <a target=xrefwindow id=d2753e1761 href="http://www.ncbi.nlm.nih.gov/pubmed/24927239">PubMed Abstract </a> | <a target=xrefwindow id=d2753e1764 href="http://dx.doi.org/10.1097/WCO.0000000000000109">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d2753e1773 class=n-a></a>Caroli A, Prestia A, Chen K, <i> et al.</i>: Summary metrics to assess Alzheimer disease-related hypometabolic pattern with <sup>18</sup>F-FDG PET: head-to-head comparison. <i>J Nucl Med.</i> 2012; <b>53</b>(4): 592–600. <a target=xrefwindow id=d2753e1787 href="http://www.ncbi.nlm.nih.gov/pubmed/22343502">PubMed Abstract </a> | <a target=xrefwindow id=d2753e1791 href="http://dx.doi.org/10.2967/jnumed.111.094946">Publisher Full Text </a> | <a target=xrefwindow id=d2753e1794 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3640308">Free Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718050012"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2753e1803 class=n-a></a>Frisoni GB, Bocchetta M, Chételat G, <i> et al.</i>: Imaging markers for Alzheimer disease: which vs how. <i>Neurology.</i> 2013; <b>81</b>(5): 487–500. <a target=xrefwindow id=d2753e1814 href="http://www.ncbi.nlm.nih.gov/pubmed/23897875">PubMed Abstract </a> | <a target=xrefwindow id=d2753e1817 href="http://dx.doi.org/10.1212/WNL.0b013e31829d86e8">Publisher Full Text </a> | <a target=xrefwindow id=d2753e1821 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3776529">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718050012">F1000 Recommendation</a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d2753e1835 class=n-a></a>Perani D, Schillaci O, Padovani A, <i> et al.</i>: A survey of FDG- and amyloid-PET imaging in dementia and GRADE analysis. <i>Biomed Res Int.</i> 2014; <b>2014</b>: 785039. <a target=xrefwindow id=d2753e1846 href="http://www.ncbi.nlm.nih.gov/pubmed/24772437">PubMed Abstract </a> | <a target=xrefwindow id=d2753e1849 href="http://dx.doi.org/10.1155/2014/785039">Publisher Full Text </a> | <a target=xrefwindow id=d2753e1853 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3977528">Free Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d2753e1862 class=n-a></a>Frisoni GB, Perani D, Bastianello S, <i> et al.</i>: Biomarkers for the diagnosis of Alzheimer's disease in clinical practice: an Italian intersocietal roadmap. <i>Neurobiol Aging.</i> 2017; <b>52</b>: 119–31. <a target=xrefwindow id=d2753e1873 href="http://www.ncbi.nlm.nih.gov/pubmed/28317643">PubMed Abstract </a> | <a target=xrefwindow id=d2753e1876 href="http://dx.doi.org/10.1016/j.neurobiolaging.2016.02.033">Publisher Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d2753e1885 class=n-a></a>Sokoloff L: Localization of functional activity in the central nervous system by measurement of glucose utilization with radioactive deoxyglucose. <i>J Cereb Blood Flow Metab.</i> 1981; <b>1</b>(1): 7–36. <a target=xrefwindow id=d2753e1893 href="http://www.ncbi.nlm.nih.gov/pubmed/7035471">PubMed Abstract </a> | <a target=xrefwindow id=d2753e1896 href="http://dx.doi.org/10.1038/jcbfm.1981.4">Publisher Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d2753e1905 class=n-a></a>Kadekaro M, Vance WH, Terrell ML, <i> et al.</i>: Effects of antidromic stimulation of the ventral root on glucose utilization in the ventral horn of the spinal cord in the rat. <i>Proc Natl Acad Sci U S A.</i> 1987; <b>84</b>(15): 5492–5. <a target=xrefwindow id=d2753e1916 href="http://www.ncbi.nlm.nih.gov/pubmed/3474665">PubMed Abstract </a> | <a target=xrefwindow id=d2753e1919 href="http://dx.doi.org/10.1073/pnas.84.15.5492">Publisher Full Text </a> | <a target=xrefwindow id=d2753e1923 href="http://www.ncbi.nlm.nih.gov/pmc/articles/298885">Free Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d2753e1932 class=n-a></a>Pellerin L, Magistretti PJ: Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. <i>Proc Natl Acad Sci U S A.</i> 1994; <b>91</b>(22): 10625–9. <a target=xrefwindow id=d2753e1940 href="http://www.ncbi.nlm.nih.gov/pubmed/7938003">PubMed Abstract </a> | <a target=xrefwindow id=d2753e1943 href="http://dx.doi.org/10.1073/pnas.91.22.10625">Publisher Full Text </a> | <a target=xrefwindow id=d2753e1946 href="http://www.ncbi.nlm.nih.gov/pmc/articles/45074">Free Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725446900"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2753e1955 class=n-a></a>Lundgaard I, Li B, Xie L, <i> et al.</i>: Direct neuronal glucose uptake heralds activity-dependent increases in cerebral metabolism. <i>Nat Commun.</i> 2015; <b>6</b>: 6807. <a target=xrefwindow id=d2753e1966 href="http://www.ncbi.nlm.nih.gov/pubmed/25904018">PubMed Abstract </a> | <a target=xrefwindow id=d2753e1969 href="http://dx.doi.org/10.1038/ncomms7807">Publisher Full Text </a> | <a target=xrefwindow id=d2753e1973 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4410436">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725446900">F1000 Recommendation</a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d2753e1987 class=n-a></a>Zimmer ER, Parent MJ, Souza DG, <i> et al.</i>: [<sup>18</sup>F]FDG PET signal is driven by astroglial glutamate transport. <i>Nat Neurosci.</i> 2017; <b>20</b>(3): 393–5. <a target=xrefwindow id=d2753e2001 href="http://www.ncbi.nlm.nih.gov/pubmed/28135241">PubMed Abstract </a> | <a target=xrefwindow id=d2753e2005 href="http://dx.doi.org/10.1038/nn.4492">Publisher Full Text </a> | <a target=xrefwindow id=d2753e2008 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5378483">Free Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d2753e2017 class=n-a></a>Kato T, Inui Y, Nakamura A, <i> et al.</i>: Brain fluorodeoxyglucose (FDG) PET in dementia. <i>Ageing Res Rev.</i> 2016; <b>30</b>: 73–84. <a target=xrefwindow id=d2753e2028 href="http://www.ncbi.nlm.nih.gov/pubmed/26876244">PubMed Abstract </a> | <a target=xrefwindow id=d2753e2031 href="http://dx.doi.org/10.1016/j.arr.2016.02.003">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d2753e2040 class=n-a></a>Teune LK, Bartels AL, de Jong BM, <i> et al.</i>: Typical cerebral metabolic patterns in neurodegenerative brain diseases. <i>Mov Disord.</i> 2010; <b>25</b>(14): 2395–404. <a target=xrefwindow id=d2753e2051 href="http://www.ncbi.nlm.nih.gov/pubmed/20669302">PubMed Abstract </a> | <a target=xrefwindow id=d2753e2054 href="http://dx.doi.org/10.1002/mds.23291">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d2753e2063 class=n-a></a>Iaccarino L, Crespi C, Della Rosa PA, <i> et al.</i>: The semantic variant of primary progressive aphasia: clinical and neuroimaging evidence in single subjects. <i>PLoS One.</i> 2015; <b>10</b>(3): e0120197. <a target=xrefwindow id=d2753e2074 href="http://www.ncbi.nlm.nih.gov/pubmed/25756991">PubMed Abstract </a> | <a target=xrefwindow id=d2753e2077 href="http://dx.doi.org/10.1371/journal.pone.0120197">Publisher Full Text </a> | <a target=xrefwindow id=d2753e2081 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4354903">Free Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d2753e2090 class=n-a></a>Teipel S, Drzezga A, Grothe MJ, <i> et al.</i>: Multimodal imaging in Alzheimer's disease: validity and usefulness for early detection. <i>Lancet Neurol.</i> 2015; <b>14</b>(10): 1037–53. <a target=xrefwindow id=d2753e2101 href="http://www.ncbi.nlm.nih.gov/pubmed/26318837">PubMed Abstract </a> | <a target=xrefwindow id=d2753e2104 href="http://dx.doi.org/10.1016/S1474-4422(15)00093-9">Publisher Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d2753e2113 class=n-a></a>Cerami C, Dodich A, Greco L, <i> et al.</i>: The Role of Single-Subject Brain Metabolic Patterns in the Early Differential Diagnosis of Primary Progressive Aphasias and in Prediction of Progression to Dementia. <i>J Alzheimers Dis.</i> 2017; <b>55</b>(1): 183–97. <a target=xrefwindow id=d2753e2124 href="http://www.ncbi.nlm.nih.gov/pubmed/27662315">PubMed Abstract </a> | <a target=xrefwindow id=d2753e2127 href="http://dx.doi.org/10.3233/JAD-160682">Publisher Full Text </a> | <a target=xrefwindow id=d2753e2131 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5115609">Free Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d2753e2141 class=n-a></a>Cerami C, Dodich A, Lettieri G, <i> et al.</i>: Different FDG-PET metabolic patterns at single-subject level in the behavioral variant of fronto-temporal dementia. <i>Cortex.</i> 2016; <b>83</b>: 101–12. <a target=xrefwindow id=d2753e2152 href="http://www.ncbi.nlm.nih.gov/pubmed/27498041">PubMed Abstract </a> | <a target=xrefwindow id=d2753e2155 href="http://dx.doi.org/10.1016/j.cortex.2016.07.008">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d2753e2164 class=n-a></a>Perani D, Cerami C, Caminiti SP, <i> et al.</i>: Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical setting. <i>Eur J Nucl Med Mol Imaging.</i> 2016; <b>43</b>(3): 499–508. <a target=xrefwindow id=d2753e2175 href="http://www.ncbi.nlm.nih.gov/pubmed/26341365">PubMed Abstract </a> | <a target=xrefwindow id=d2753e2178 href="http://dx.doi.org/10.1007/s00259-015-3170-y">Publisher Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d2753e2187 class=n-a></a>Caminiti SP, Alongi P, Majno L, <i> et al.</i>: Evaluation of an optimized [<sup>18</sup>F]fluoro-deoxy-glucose positron emission tomography voxel-wise method to early support differential diagnosis in atypical Parkinsonian disorders. <i>Eur J Neurol.</i> 2017; <b>24</b>(5): 687–e26. <a target=xrefwindow id=d2753e2201 href="http://www.ncbi.nlm.nih.gov/pubmed/28244178">PubMed Abstract </a> | <a target=xrefwindow id=d2753e2205 href="http://dx.doi.org/10.1111/ene.13269">Publisher Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717948965"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2753e2214 class=n-a></a>Bateman RJ, Xiong C, Benzinger TL, <i> et al.</i>: Clinical and biomarker changes in dominantly inherited Alzheimer's disease. <i>N Engl J Med.</i> 2012; <b>367</b>(9): 795–804. <a target=xrefwindow id=d2753e2225 href="http://www.ncbi.nlm.nih.gov/pubmed/22784036">PubMed Abstract </a> | <a target=xrefwindow id=d2753e2228 href="http://dx.doi.org/10.1056/NEJMoa1202753">Publisher Full Text </a> | <a target=xrefwindow id=d2753e2232 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3474597">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717948965">F1000 Recommendation</a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d2753e2245 class=n-a></a>Chételat G, Desgranges B, Landeau B, <i> et al.</i>: Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease. <i>Brain.</i> 2008; <b>131</b>(Pt 1): 60–71. <a target=xrefwindow id=d2753e2256 href="http://www.ncbi.nlm.nih.gov/pubmed/18063588">PubMed Abstract </a> | <a target=xrefwindow id=d2753e2259 href="http://dx.doi.org/10.1093/brain/awm288">Publisher Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d2753e2268 class=n-a></a>Cerami C, Crespi C, Della Rosa PA, <i> et al.</i>: Brain changes within the visuo-spatial attentional network in posterior cortical atrophy. <i>J Alzheimers Dis.</i> 2015; <b>43</b>(2): 385–95. <a target=xrefwindow id=d2753e2279 href="http://www.ncbi.nlm.nih.gov/pubmed/25114070">PubMed Abstract </a> | <a target=xrefwindow id=d2753e2282 href="http://dx.doi.org/10.3233/JAD-141275">Publisher Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d2753e2292 class=n-a></a>Perani D, Della Rosa PA, Cerami C, <i> et al.</i>: Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting. <i>Neuroimage Clin.</i> 2014; <b>6</b>: 445–54. <a target=xrefwindow id=d2753e2303 href="http://www.ncbi.nlm.nih.gov/pubmed/25389519">PubMed Abstract </a> | <a target=xrefwindow id=d2753e2306 href="http://dx.doi.org/10.1016/j.nicl.2014.10.009">Publisher Full Text </a> | <a target=xrefwindow id=d2753e2310 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4225527">Free Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d2753e2319 class=n-a></a>Berti V, Polito C, Lombardi G, <i> et al.</i>: Rethinking on the concept of biomarkers in preclinical Alzheimer's disease. <i>Neurol Sci.</i> 2016; <b>37</b>(5): 663–72. <a target=xrefwindow id=d2753e2330 href="http://www.ncbi.nlm.nih.gov/pubmed/26792010">PubMed Abstract </a> | <a target=xrefwindow id=d2753e2333 href="http://dx.doi.org/10.1007/s10072-016-2477-1">Publisher Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d2753e2342 class=n-a></a>Cerami C, Della Rosa PA, Magnani G, <i> et al.</i>: Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia. <i>Neuroimage Clin.</i> 2015; <b>7</b>: 187–94. <a target=xrefwindow id=d2753e2353 href="http://www.ncbi.nlm.nih.gov/pubmed/25610780">PubMed Abstract </a> | <a target=xrefwindow id=d2753e2356 href="http://dx.doi.org/10.1016/j.nicl.2014.12.004">Publisher Full Text </a> | <a target=xrefwindow id=d2753e2360 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4300010">Free Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d2753e2369 class=n-a></a>Iaccarino L, Chiotis K, Alongi P, <i> et al.</i>: A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting. <i>J Alzheimers Dis.</i> 2017; <b>59</b>(2): 603–14. <a target=xrefwindow id=d2753e2380 href="http://www.ncbi.nlm.nih.gov/pubmed/28671117">PubMed Abstract </a> | <a target=xrefwindow id=d2753e2383 href="http://dx.doi.org/10.3233/JAD-170158">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727466374"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2753e2392 class=n-a></a>Garibotto V, Herholz K, Boccardi M, <i> et al.</i>: Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework. <i>Neurobiol Aging.</i> 2017; <b>52</b>: 183–95. <a target=xrefwindow id=d2753e2403 href="http://www.ncbi.nlm.nih.gov/pubmed/28317648">PubMed Abstract </a> | <a target=xrefwindow id=d2753e2406 href="http://dx.doi.org/10.1016/j.neurobiolaging.2016.03.033">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727466374">F1000 Recommendation</a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d2753e2419 class=n-a></a>Perani D: FDG PET and cognitive symptoms of dementia. <i>Clin Transl Imaging.</i> 2013; <b>1</b>(4): 247–60. <a target=xrefwindow id=d2753e2427 href="http://dx.doi.org/10.1007/s40336-013-0029-8">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d2753e2437 class=n-a></a>Potkin SG, Anand R, Fleming K, <i> et al.</i>: Brain metabolic and clinical effects of rivastigmine in Alzheimer's disease. <i>Int J Neuropsychopharmacol.</i> 2001; <b>4</b>(3): 223–30. <a target=xrefwindow id=d2753e2448 href="http://www.ncbi.nlm.nih.gov/pubmed/11602028">PubMed Abstract </a> | <a target=xrefwindow id=d2753e2451 href="http://dx.doi.org/10.1017/S1461145701002528">Publisher Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d2753e2460 class=n-a></a>Smith GS, Kramer E, Ma Y, <i> et al.</i>: Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimer's disease. <i>Brain.</i> 2009; <b>132</b>(Pt 2): 392–401. <a target=xrefwindow id=d2753e2471 href="http://www.ncbi.nlm.nih.gov/pubmed/19153152">PubMed Abstract </a> | <a target=xrefwindow id=d2753e2474 href="http://dx.doi.org/10.1093/brain/awn326">Publisher Full Text </a> | <a target=xrefwindow id=d2753e2478 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2640217">Free Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d2753e2487 class=n-a></a>Satoh M, Ishikawa H, Meguro K, <i> et al.</i>: Improved visual hallucination by donepezil and occipital glucose metabolism in dementia with Lewy bodies: the Osaki-Tajiri project. <i>Eur Neurol.</i> 2010; <b>64</b>(6): 337–44. <a target=xrefwindow id=d2753e2498 href="http://www.ncbi.nlm.nih.gov/pubmed/21071950">PubMed Abstract </a> | <a target=xrefwindow id=d2753e2501 href="http://dx.doi.org/10.1159/000322121">Publisher Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d2753e2510 class=n-a></a>Sultzer DL, Melrose RJ, Harwood DG, <i> et al.</i>: Effect of memantine treatment on regional cortical metabolism in Alzheimer's disease. <i>Am J Geriatr Psychiatry.</i> 2010; <b>18</b>(7): 606–14. <a target=xrefwindow id=d2753e2521 href="http://www.ncbi.nlm.nih.gov/pubmed/20220580">PubMed Abstract </a> | <a target=xrefwindow id=d2753e2524 href="http://dx.doi.org/10.1097/JGP.0b013e3181ca3a4e">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d2753e2533 class=n-a></a>Keller C, Kadir A, Forsberg A, <i> et al.</i>: Long-term effects of galantamine treatment on brain functional activities as measured by PET in Alzheimer's disease patients. <i>J Alzheimers Dis.</i> 2011; <b>24</b>(1): 109–23. <a target=xrefwindow id=d2753e2544 href="http://www.ncbi.nlm.nih.gov/pubmed/21157026">PubMed Abstract </a> | <a target=xrefwindow id=d2753e2547 href="http://dx.doi.org/10.3233/JAD-2010-101290">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d2753e2556 class=n-a></a>Chow TW, Fam D, Graff-Guerrero A, <i> et al.</i>: Fluorodeoxyglucose positron emission tomography in semantic dementia after 6 months of memantine: an open-label pilot study. <i>Int J Geriatr Psychiatry.</i> 2013; <b>28</b>(3): 319–25. <a target=xrefwindow id=d2753e2567 href="http://www.ncbi.nlm.nih.gov/pubmed/22674572">PubMed Abstract </a> | <a target=xrefwindow id=d2753e2570 href="http://dx.doi.org/10.1002/gps.3832">Publisher Full Text </a> | <a target=xrefwindow id=d2753e2574 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3467357">Free Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d2753e2584 class=n-a></a>Smailagic N, Vacante M, Hyde C, <i> et al.</i>: <sup>18</sup>F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). <i>Cochrane Database Syst Rev.</i> 2015; <b>1</b>: CD010632. <a target=xrefwindow id=d2753e2598 href="http://www.ncbi.nlm.nih.gov/pubmed/25629415">PubMed Abstract </a> | <a target=xrefwindow id=d2753e2602 href="http://dx.doi.org/10.1002/14651858.CD010632.pub2">Publisher Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d2753e2611 class=n-a></a>Morbelli S, Garibotto V, Van De Giessen E, <i> et al.</i>: A Cochrane review on brain [<sup>18</sup>F]FDG PET in dementia: limitations and future perspectives. <i>Eur J Nucl Med Mol Imaging.</i> 2015; <b>42</b>(10): 1487–91. <a target=xrefwindow id=d2753e2625 href="http://www.ncbi.nlm.nih.gov/pubmed/26067090">PubMed Abstract </a> | <a target=xrefwindow id=d2753e2629 href="http://dx.doi.org/10.1007/s00259-015-3098-2">Publisher Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d2753e2638 class=n-a></a>Friston KJ, Holmes AP, Worsley KJ, <i> et al.</i>: Statistical parametric maps in functional imaging: A general linear approach. <i>Hum Brain Mapp.</i> 1994; <b>2</b>(4): 189–210. <a target=xrefwindow id=d2753e2649 href="http://dx.doi.org/10.1002/hbm.460020402">Publisher Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d2753e2658 class=n-a></a>Minoshima S, Koeppe RA, Frey KA, <i> et al.</i>: Anatomic standardization: linear scaling and nonlinear warping of functional brain images. <i>J Nucl Med.</i> 1994; <b>35</b>(9): 1528–37. <a target=xrefwindow id=d2753e2669 href="http://www.ncbi.nlm.nih.gov/pubmed/8071705">PubMed Abstract </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d2753e2678 class=n-a></a>Minoshima S, Frey KA, Koeppe RA, <i> et al.</i>: A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. <i>J Nucl Med.</i> 1995; <b>36</b>(7): 1238–48. <a target=xrefwindow id=d2753e2689 href="http://www.ncbi.nlm.nih.gov/pubmed/7790950">PubMed Abstract </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d2753e2698 class=n-a></a>Ishii K, Willoch F, Minoshima S, <i> et al.</i>: Statistical brain mapping of <sup>18</sup>F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains. <i>J Nucl Med.</i> 2001; <b>42</b>(4): 548–57. <a target=xrefwindow id=d2753e2712 href="http://www.ncbi.nlm.nih.gov/pubmed/11337540">PubMed Abstract </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d2753e2722 class=n-a></a>Della Rosa PA, Cerami C, Gallivanone F, <i> et al.</i>: A standardized [<sup>18</sup>F]-FDG-PET template for spatial normalization in statistical parametric mapping of dementia. <i>Neuroinformatics.</i> 2014; <b>12</b>(4): 575–93. <a target=xrefwindow id=d2753e2736 href="http://www.ncbi.nlm.nih.gov/pubmed/24952892">PubMed Abstract </a> | <a target=xrefwindow id=d2753e2740 href="http://dx.doi.org/10.1007/s12021-014-9235-4">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d2753e2749 class=n-a></a>Lee DS, Kang H, Kim H, <i> et al.</i>: Metabolic connectivity by interregional correlation analysis using statistical parametric mapping (SPM) and FDG brain PET; methodological development and patterns of metabolic connectivity in adults. <i>Eur J Nucl Med Mol Imaging.</i> 2008; <b>35</b>(9): 1681–91. <a target=xrefwindow id=d2753e2760 href="http://www.ncbi.nlm.nih.gov/pubmed/18491089">PubMed Abstract </a> | <a target=xrefwindow id=d2753e2763 href="http://dx.doi.org/10.1007/s00259-008-0808-z">Publisher Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d2753e2772 class=n-a></a>Huang S, Li J, Sun L, <i> et al.</i>: Learning brain connectivity of Alzheimer's disease by sparse inverse covariance estimation. <i>Neuroimage.</i> 2010; <b>50</b>(3): 935–49. <a target=xrefwindow id=d2753e2783 href="http://www.ncbi.nlm.nih.gov/pubmed/20079441">PubMed Abstract </a> | <a target=xrefwindow id=d2753e2786 href="http://dx.doi.org/10.1016/j.neuroimage.2009.12.120">Publisher Full Text </a> | <a target=xrefwindow id=d2753e2790 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3068623">Free Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d2753e2799 class=n-a></a>Horwitz B, Duara R, Rapoport SI: Intercorrelations of glucose metabolic rates between brain regions: application to healthy males in a state of reduced sensory input. <i>J Cereb Blood Flow Metab.</i> 1984; <b>4</b>(4): 484–99. <a target=xrefwindow id=d2753e2807 href="http://www.ncbi.nlm.nih.gov/pubmed/6501442">PubMed Abstract </a> | <a target=xrefwindow id=d2753e2810 href="http://dx.doi.org/10.1038/jcbfm.1984.73">Publisher Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d2753e2819 class=n-a></a>Pievani M, Filippini N, van den Heuvel MP, <i> et al.</i>: Brain connectivity in neurodegenerative diseases--from phenotype to proteinopathy. <i>Nat Rev Neurol.</i> 2014; <b>10</b>(11): 620–33. <a target=xrefwindow id=d2753e2830 href="http://www.ncbi.nlm.nih.gov/pubmed/25287597">PubMed Abstract </a> | <a target=xrefwindow id=d2753e2833 href="http://dx.doi.org/10.1038/nrneurol.2014.178">Publisher Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d2753e2842 class=n-a></a>Morbelli S, Drzezga A, Perneczky R, <i> et al.</i>: Resting metabolic connectivity in prodromal Alzheimer's disease. A European Alzheimer Disease Consortium (EADC) project. <i>Neurobiol Aging.</i> 2012; <b>33</b>(11): 2533–50. <a target=xrefwindow id=d2753e2853 href="http://www.ncbi.nlm.nih.gov/pubmed/22365486">PubMed Abstract </a> | <a target=xrefwindow id=d2753e2856 href="http://dx.doi.org/10.1016/j.neurobiolaging.2012.01.005">Publisher Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d2753e2866 class=n-a></a>Sanabria-Diaz G, Martínez-Montes E, Melie-Garcia L, <i> et al.</i>: Glucose metabolism during resting state reveals abnormal brain networks organization in the Alzheimer's disease and mild cognitive impairment. <i>PLoS One.</i> 2013; <b>8</b>(7): e68860. <a target=xrefwindow id=d2753e2877 href="http://www.ncbi.nlm.nih.gov/pubmed/23894356">PubMed Abstract </a> | <a target=xrefwindow id=d2753e2880 href="http://dx.doi.org/10.1371/journal.pone.0068860">Publisher Full Text </a> | <a target=xrefwindow id=d2753e2884 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3720883">Free Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d2753e2893 class=n-a></a>Caminiti SP, Tettamanti M, Sala A, <i> et al.</i>: Metabolic connectomics targeting brain pathology in dementia with Lewy bodies. <i>J Cereb Blood Flow Metab.</i> 2017; <b>37</b>(4): 1311–25. <a target=xrefwindow id=d2753e2904 href="http://www.ncbi.nlm.nih.gov/pubmed/27306756">PubMed Abstract </a> | <a target=xrefwindow id=d2753e2907 href="http://dx.doi.org/10.1177/0271678X16654497">Publisher Full Text </a> | <a target=xrefwindow id=d2753e2911 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5453453">Free Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d2753e2920 class=n-a></a>Sala A, Caminiti SP, Presotto L, <i> et al.</i>: Altered brain metabolic connectivity at multiscale level in early Parkinson's disease. <i>Sci Rep.</i> 2017; <b>7</b>(1): 4256. <a target=xrefwindow id=d2753e2931 href="http://www.ncbi.nlm.nih.gov/pubmed/28652595">PubMed Abstract </a> | <a target=xrefwindow id=d2753e2934 href="http://dx.doi.org/10.1038/s41598-017-04102-z">Publisher Full Text </a> | <a target=xrefwindow id=d2753e2938 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5484707">Free Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d2753e2947 class=n-a></a>Agdeppa ED, Kepe V, Liu J, <i> et al.</i>: Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease. <i>J Neurosci.</i> 2001; <b>21</b>(24): RC189. <a target=xrefwindow id=d2753e2958 href="http://www.ncbi.nlm.nih.gov/pubmed/11734604">PubMed Abstract </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d2753e2967 class=n-a></a>Masdeu JC: Future Directions in Imaging Neurodegeneration. <i>Curr Neurol Neurosci Rep.</i> 2017; <b>17</b>(1): 9. <a target=xrefwindow id=d2753e2975 href="http://www.ncbi.nlm.nih.gov/pubmed/28210978">PubMed Abstract </a> | <a target=xrefwindow id=d2753e2978 href="http://dx.doi.org/10.1007/s11910-017-0718-1">Publisher Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d2753e2987 class=n-a></a>Landau SM, Thomas BA, Thurfjell L, <i> et al.</i>: Amyloid PET imaging in Alzheimer's disease: a comparison of three radiotracers. <i>Eur J Nucl Med Mol Imaging.</i> 2014; <b>41</b>(7): 1398–407. <a target=xrefwindow id=d2753e2998 href="http://www.ncbi.nlm.nih.gov/pubmed/24647577">PubMed Abstract </a> | <a target=xrefwindow id=d2753e3001 href="http://dx.doi.org/10.1007/s00259-014-2753-3">Publisher Full Text </a> | <a target=xrefwindow id=d2753e3005 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4055504">Free Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d2753e3015 class=n-a></a>Minoshima S, Drzezga AE, Barthel H, <i> et al.</i>: SNMMI Procedure Standard/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0. <i>J Nucl Med.</i> 2016; <b>57</b>(8): 1316–22. <a target=xrefwindow id=d2753e3026 href="http://www.ncbi.nlm.nih.gov/pubmed/27481605">PubMed Abstract </a> | <a target=xrefwindow id=d2753e3029 href="http://dx.doi.org/10.2967/jnumed.116.174615">Publisher Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d2753e3038 class=n-a></a>Klunk WE, Koeppe RA, Price JC, <i> et al.</i>: The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET. <i>Alzheimers Dement.</i> 2015; <b>11</b>(1): 1–15.e1–4. <a target=xrefwindow id=d2753e3049 href="http://www.ncbi.nlm.nih.gov/pubmed/25443857">PubMed Abstract </a> | <a target=xrefwindow id=d2753e3052 href="http://dx.doi.org/10.1016/j.jalz.2014.07.003">Publisher Full Text </a> | <a target=xrefwindow id=d2753e3056 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4300247">Free Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d2753e3065 class=n-a></a>Klunk WE, Engler H, Nordberg A, <i> et al.</i>: Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. <i>Ann Neurol.</i> 2004; <b>55</b>(3): 306–19. <a target=xrefwindow id=d2753e3076 href="http://www.ncbi.nlm.nih.gov/pubmed/14991808">PubMed Abstract </a> | <a target=xrefwindow id=d2753e3079 href="http://dx.doi.org/10.1002/ana.20009">Publisher Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d2753e3088 class=n-a></a>Choi SR, Schneider JA, Bennett DA, <i> et al.</i>: Correlation of amyloid PET ligand florbetapir F 18 binding with Aβ aggregation and neuritic plaque deposition in postmortem brain tissue. <i>Alzheimer Dis Assoc Disord.</i> 2012; <b>26</b>(1): 8–16. <a target=xrefwindow id=d2753e3099 href="http://www.ncbi.nlm.nih.gov/pubmed/22354138">PubMed Abstract </a> | <a target=xrefwindow id=d2753e3102 href="http://dx.doi.org/10.1097/WAD.0b013e31821300bc">Publisher Full Text </a> | <a target=xrefwindow id=d2753e3106 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3286131">Free Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d2753e3115 class=n-a></a>Wolk DA, Grachev ID, Buckley C, <i> et al.</i>: Association between <i>in vivo</i> fluorine 18-labeled flutemetamol amyloid positron emission tomography imaging and <i>in vivo</i> cerebral cortical histopathology. <i>Arch Neurol.</i> 2011; <b>68</b>(11): 1398–403. <a target=xrefwindow id=d2753e3133 href="http://www.ncbi.nlm.nih.gov/pubmed/21747004">PubMed Abstract </a> | <a target=xrefwindow id=d2753e3136 href="http://dx.doi.org/10.1001/archneurol.2011.153">Publisher Full Text </a> | <a target=xrefwindow id=d2753e3139 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4532383">Free Full Text </a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d2753e3148 class=n-a></a>Sabri O, Sabbagh MN, Seibyl J, <i> et al.</i>: Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: phase 3 study. <i>Alzheimers Dement.</i> 2015; <b>11</b>(8): 964–74. <a target=xrefwindow id=d2753e3159 href="http://www.ncbi.nlm.nih.gov/pubmed/25824567">PubMed Abstract </a> | <a target=xrefwindow id=d2753e3162 href="http://dx.doi.org/10.1016/j.jalz.2015.02.004">Publisher Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d2753e3172 class=n-a></a>Seo SW, Ayakta N, Grinberg LT, <i> et al.</i>: Regional correlations between [<sup>11</sup>C]PIB PET and post-mortem burden of amyloid-beta pathology in a diverse neuropathological cohort. <i>Neuroimage Clin.</i> 2017; <b>13</b>: 130–7. <a target=xrefwindow id=d2753e3186 href="http://www.ncbi.nlm.nih.gov/pubmed/27981028">PubMed Abstract </a> | <a target=xrefwindow id=d2753e3190 href="http://dx.doi.org/10.1016/j.nicl.2016.11.008">Publisher Full Text </a> | <a target=xrefwindow id=d2753e3193 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5144753">Free Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725515053"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2753e3202 class=n-a></a>Herrup K: The case for rejecting the amyloid cascade hypothesis. <i>Nat Neurosci.</i> 2015; <b>18</b>(6): 794–9. <a target=xrefwindow id=d2753e3210 href="http://www.ncbi.nlm.nih.gov/pubmed/26007212">PubMed Abstract </a> | <a target=xrefwindow id=d2753e3213 href="http://dx.doi.org/10.1038/nn.4017">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725515053">F1000 Recommendation</a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d2753e3226 class=n-a></a>Villemagne VL, Doré V, Bourgeat P, <i> et al.</i>: Aβ-amyloid and Tau Imaging in Dementia. <i>Semin Nucl Med.</i> 2017; <b>47</b>(1): 75–88. <a target=xrefwindow id=d2753e3237 href="http://www.ncbi.nlm.nih.gov/pubmed/27987560">PubMed Abstract </a> | <a target=xrefwindow id=d2753e3240 href="http://dx.doi.org/10.1053/j.semnuclmed.2016.09.006">Publisher Full Text </a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d2753e3249 class=n-a></a>Chételat G, Ossenkoppele R, Villemagne VL, <i> et al.</i>: Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer's disease. <i>Brain.</i> 2016; <b>139</b>(Pt 9): 2528–39. <a target=xrefwindow id=d2753e3260 href="http://www.ncbi.nlm.nih.gov/pubmed/27357349">PubMed Abstract </a> | <a target=xrefwindow id=d2753e3263 href="http://dx.doi.org/10.1093/brain/aww159">Publisher Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d2753e3272 class=n-a></a>Johnson KA, Minoshima S, Bohnen NI, <i> et al.</i>: Update on appropriate use criteria for amyloid PET imaging: dementia experts, mild cognitive impairment, and education. Amyloid Imaging Task Force of the Alzheimer’s Association and Society for Nuclear Medicine and Molecular Imaging. <i>Alzheimers Dement.</i> 2013; <b>9</b>(4): e106–9. <a target=xrefwindow id=d2753e3283 href="http://www.ncbi.nlm.nih.gov/pubmed/23809369">PubMed Abstract </a> | <a target=xrefwindow id=d2753e3286 href="http://dx.doi.org/10.1016/j.jalz.2013.06.001">Publisher Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d2753e3295 class=n-a></a>Guerra UP, Nobili FM, Padovani A, <i> et al.</i>: Recommendations from the Italian Interdisciplinary Working Group (AIMN, AIP, SINDEM) for the utilization of amyloid imaging in clinical practice. <i>Neurol Sci.</i> 2015; <b>36</b>(6): 1075–81. <a target=xrefwindow id=d2753e3306 href="http://www.ncbi.nlm.nih.gov/pubmed/25616445">PubMed Abstract </a> | <a target=xrefwindow id=d2753e3309 href="http://dx.doi.org/10.1007/s10072-015-2079-3">Publisher Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d2753e3319 class=n-a></a>Nordberg A, Carter SF, Rinne J, <i> et al.</i>: A European multicentre PET study of fibrillar amyloid in Alzheimer's disease. <i>Eur J Nucl Med Mol Imaging.</i> 2013; <b>40</b>(1): 104–14. <a target=xrefwindow id=d2753e3330 href="http://www.ncbi.nlm.nih.gov/pubmed/22961445">PubMed Abstract </a> | <a target=xrefwindow id=d2753e3333 href="http://dx.doi.org/10.1007/s00259-012-2237-2">Publisher Full Text </a> | <a target=xrefwindow id=d2753e3337 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3510420">Free Full Text </a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d2753e3346 class=n-a></a>Hatashita S, Wakebe D: Amyloid-β Deposition and Long-Term Progression in Mild Cognitive Impairment due to Alzheimer's Disease Defined with Amyloid PET Imaging. <i>J Alzheimers Dis.</i> 2017; <b>57</b>(3): 765–73. <a target=xrefwindow id=d2753e3354 href="http://www.ncbi.nlm.nih.gov/pubmed/28304292">PubMed Abstract </a> | <a target=xrefwindow id=d2753e3357 href="http://dx.doi.org/10.3233/JAD-161074">Publisher Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d2753e3366 class=n-a></a>Jack CR Jr, Wiste HJ, Lesnick TG, <i> et al.</i>: Brain β-amyloid load approaches a plateau. <i>Neurology.</i> 2013; <b>80</b>(10): 890–6. <a target=xrefwindow id=d2753e3377 href="http://www.ncbi.nlm.nih.gov/pubmed/23446680">PubMed Abstract </a> | <a target=xrefwindow id=d2753e3380 href="http://dx.doi.org/10.1212/WNL.0b013e3182840bbe">Publisher Full Text </a> | <a target=xrefwindow id=d2753e3384 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3653215">Free Full Text </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a name=d2753e3393 class=n-a></a>Villemagne VL, Pike KE, Chételat G, <i> et al.</i>: Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease. <i>Ann Neurol.</i> 2011; <b>69</b>(1): 181–92. <a target=xrefwindow id=d2753e3404 href="http://www.ncbi.nlm.nih.gov/pubmed/21280088">PubMed Abstract </a> | <a target=xrefwindow id=d2753e3407 href="http://dx.doi.org/10.1002/ana.22248">Publisher Full Text </a> | <a target=xrefwindow id=d2753e3411 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3045039">Free Full Text </a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718011395"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2753e3420 class=n-a></a>Petersen RC, Aisen P, Boeve BF, <i> et al.</i>: Mild cognitive impairment due to Alzheimer disease in the community. <i>Ann Neurol.</i> 2013; <b>74</b>(2): 199–208. <a target=xrefwindow id=d2753e3431 href="http://www.ncbi.nlm.nih.gov/pubmed/23686697">PubMed Abstract </a> | <a target=xrefwindow id=d2753e3434 href="http://dx.doi.org/10.1002/ana.23931">Publisher Full Text </a> | <a target=xrefwindow id=d2753e3438 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3804562">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718011395">F1000 Recommendation</a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a name=d2753e3451 class=n-a></a>Landau SM, Horng A, Fero A, <i> et al.</i>: Amyloid negativity in patients with clinically diagnosed Alzheimer disease and MCI. <i>Neurology.</i> 2016; <b>86</b>(15): 1377–85. <a target=xrefwindow id=d2753e3462 href="http://www.ncbi.nlm.nih.gov/pubmed/26968515">PubMed Abstract </a> | <a target=xrefwindow id=d2753e3465 href="http://dx.doi.org/10.1212/WNL.0000000000002576">Publisher Full Text </a> | <a target=xrefwindow id=d2753e3469 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4831042">Free Full Text </a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a name=d2753e3479 class=n-a></a>Chételat G, La Joie R, Villain N, <i> et al.</i>: Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease. <i>Neuroimage Clin.</i> 2013; <b>2</b>: 356–65. <a target=xrefwindow id=d2753e3490 href="http://www.ncbi.nlm.nih.gov/pubmed/24179789">PubMed Abstract </a> | <a target=xrefwindow id=d2753e3493 href="http://dx.doi.org/10.1016/j.nicl.2013.02.006">Publisher Full Text </a> | <a target=xrefwindow id=d2753e3497 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3777672">Free Full Text </a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a name=d2753e3506 class=n-a></a>Rabinovici GD, Rosen HJ, Alkalay A, <i> et al.</i>: Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD. <i>Neurology.</i> 2011; <b>77</b>(23): 2034–42. <a target=xrefwindow id=d2753e3517 href="http://www.ncbi.nlm.nih.gov/pubmed/22131541">PubMed Abstract </a> | <a target=xrefwindow id=d2753e3520 href="http://dx.doi.org/10.1212/WNL.0b013e31823b9c5e">Publisher Full Text </a> | <a target=xrefwindow id=d2753e3524 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3236517">Free Full Text </a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725503383"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2753e3533 class=n-a></a>Jansen WJ, Ossenkoppele R, Knol DL, <i> et al.</i>: Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. <i>JAMA.</i> 2015; <b>313</b>(19): 1924–38. <a target=xrefwindow id=d2753e3544 href="http://www.ncbi.nlm.nih.gov/pubmed/25988462">PubMed Abstract </a> | <a target=xrefwindow id=d2753e3547 href="http://dx.doi.org/10.1001/jama.2015.4668">Publisher Full Text </a> | <a target=xrefwindow id=d2753e3551 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4486209">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725503383">F1000 Recommendation</a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725503382"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2753e3564 class=n-a></a>Ossenkoppele R, Jansen WJ, Rabinovici GD, <i> et al.</i>: Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis. <i>JAMA.</i> 2015; <b>313</b>(19): 1939–49. <a target=xrefwindow id=d2753e3575 href="http://www.ncbi.nlm.nih.gov/pubmed/25988463">PubMed Abstract </a> | <a target=xrefwindow id=d2753e3578 href="http://dx.doi.org/10.1001/jama.2015.4669">Publisher Full Text </a> | <a target=xrefwindow id=d2753e3582 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4517678">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725503382">F1000 Recommendation</a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717983506"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2753e3595 class=n-a></a>Lehmann M, Ghosh PM, Madison C, <i> et al.</i>: Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease. <i>Brain.</i> 2013; <b>136</b>(Pt 3): 844–58. <a target=xrefwindow id=d2753e3606 href="http://www.ncbi.nlm.nih.gov/pubmed/23358601">PubMed Abstract </a> | <a target=xrefwindow id=d2753e3609 href="http://dx.doi.org/10.1093/brain/aws327">Publisher Full Text </a> | <a target=xrefwindow id=d2753e3613 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3580269">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717983506">F1000 Recommendation</a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d2753e3626 class=n-a></a>Dronse J, Fliessbach K, Bischof GN, <i> et al.</i>: <i>In vivo</i> Patterns of Tau Pathology, Amyloid-β Burden, and Neuronal Dysfunction in Clinical Variants of Alzheimer's Disease. <i>J Alzheimers Dis.</i> 2017; <b>55</b>(2): 465–71. <a target=xrefwindow id=d2753e3640 href="http://www.ncbi.nlm.nih.gov/pubmed/27802224">PubMed Abstract </a> | <a target=xrefwindow id=d2753e3644 href="http://dx.doi.org/10.3233/JAD-160316">Publisher Full Text </a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a name=d2753e3654 class=n-a></a>Maetzler W, Liepelt I, Reimold M, <i> et al.</i>: Cortical PIB binding in Lewy body disease is associated with Alzheimer-like characteristics. <i>Neurobiol Dis.</i> 2009; <b>34</b>(1): 107–12. <a target=xrefwindow id=d2753e3665 href="http://www.ncbi.nlm.nih.gov/pubmed/19162186">PubMed Abstract </a> | <a target=xrefwindow id=d2753e3668 href="http://dx.doi.org/10.1016/j.nbd.2008.12.008">Publisher Full Text </a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a name=d2753e3677 class=n-a></a>Kantarci K, Lowe VJ, Boeve BF, <i> et al.</i>: AV-1451 tau and β-amyloid positron emission tomography imaging in dementia with Lewy bodies. <i>Ann Neurol.</i> 2017; <b>81</b>(1): 58–67. <a target=xrefwindow id=d2753e3688 href="http://www.ncbi.nlm.nih.gov/pubmed/27863444">PubMed Abstract </a> | <a target=xrefwindow id=d2753e3691 href="http://dx.doi.org/10.1002/ana.24825">Publisher Full Text </a> | <a target=xrefwindow id=d2753e3695 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5299616">Free Full Text </a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a name=d2753e3704 class=n-a></a>Baron JC, Farid K, Dolan E, <i> et al.</i>: Diagnostic utility of amyloid PET in cerebral amyloid angiopathy-related symptomatic intracerebral hemorrhage. <i>J Cereb Blood Flow Metab.</i> 2014; <b>34</b>(5): 753–8. <a target=xrefwindow id=d2753e3715 href="http://www.ncbi.nlm.nih.gov/pubmed/24619277">PubMed Abstract </a> | <a target=xrefwindow id=d2753e3718 href="http://dx.doi.org/10.1038/jcbfm.2014.43">Publisher Full Text </a> | <a target=xrefwindow id=d2753e3722 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4013776">Free Full Text </a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717959585"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2753e3731 class=n-a></a>Gurol ME, Dierksen G, Betensky R, <i> et al.</i>: Predicting sites of new hemorrhage with amyloid imaging in cerebral amyloid angiopathy. <i>Neurology.</i> 2012; <b>79</b>(4): 320–6. <a target=xrefwindow id=d2753e3742 href="http://www.ncbi.nlm.nih.gov/pubmed/22786597">PubMed Abstract </a> | <a target=xrefwindow id=d2753e3745 href="http://dx.doi.org/10.1212/WNL.0b013e31826043a9">Publisher Full Text </a> | <a target=xrefwindow id=d2753e3749 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3400097">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717959585">F1000 Recommendation</a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a name=d2753e3762 class=n-a></a>Nordberg A: Dementia in 2014. Towards early diagnosis in Alzheimer disease. <i>Nat Rev Neurol.</i> 2015; <b>11</b>(2): 69–70. <a target=xrefwindow id=d2753e3770 href="http://www.ncbi.nlm.nih.gov/pubmed/25623789">PubMed Abstract </a> | <a target=xrefwindow id=d2753e3773 href="http://dx.doi.org/10.1038/nrneurol.2014.257">Publisher Full Text </a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a name=d2753e3782 class=n-a></a>Roberts BR, Lind M, Wagen AZ, <i> et al.</i>: Biochemically-defined pools of amyloid-β in sporadic Alzheimer's disease: correlation with amyloid PET. <i>Brain.</i> 2017; <b>140</b>(5): 1486–1498. <a target=xrefwindow id=d2753e3793 href="http://www.ncbi.nlm.nih.gov/pubmed/28383676">PubMed Abstract </a> | <a target=xrefwindow id=d2753e3796 href="http://dx.doi.org/10.1093/brain/awx057">Publisher Full Text </a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717988744"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2753e3806 class=n-a></a>Villemagne VL, Burnham S, Bourgeat P, <i> et al.</i>: Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study. <i>Lancet Neurol.</i> 2013; <b>12</b>(4): 357–67. <a target=xrefwindow id=d2753e3817 href="http://www.ncbi.nlm.nih.gov/pubmed/23477989">PubMed Abstract </a> | <a target=xrefwindow id=d2753e3820 href="http://dx.doi.org/10.1016/S1474-4422(13)70044-9">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717988744">F1000 Recommendation</a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a name=d2753e3833 class=n-a></a>van Berckel BN, Ossenkoppele R, Tolboom N, <i> et al.</i>: Longitudinal amyloid imaging using <sup>11</sup>C-PiB: methodologic considerations. <i>J Nucl Med.</i> 2013; <b>54</b>(9): 1570–6. <a target=xrefwindow id=d2753e3847 href="http://www.ncbi.nlm.nih.gov/pubmed/23940304">PubMed Abstract </a> | <a target=xrefwindow id=d2753e3851 href="http://dx.doi.org/10.2967/jnumed.112.113654">Publisher Full Text </a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a name=d2753e3860 class=n-a></a>Edison P, Hinz R, Ramlackhansingh A, <i> et al.</i>: Can target-to-pons ratio be used as a reliable method for the analysis of [<sup>11</sup>C]PIB brain scans? <i>Neuroimage.</i> 2012; <b>60</b>(3): 1716–23. <a target=xrefwindow id=d2753e3874 href="http://www.ncbi.nlm.nih.gov/pubmed/22306804">PubMed Abstract </a> | <a target=xrefwindow id=d2753e3878 href="http://dx.doi.org/10.1016/j.neuroimage.2012.01.099">Publisher Full Text </a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a name=d2753e3887 class=n-a></a>Schwarz CG, Senjem ML, Gunter JL, <i> et al.</i>: Optimizing PiB-PET SUVR change-over-time measurement by a large-scale analysis of longitudinal reliability, plausibility, separability, and correlation with MMSE. <i>Neuroimage.</i> 2017; <b>144</b>(Pt A): 113–27. <a target=xrefwindow id=d2753e3898 href="http://www.ncbi.nlm.nih.gov/pubmed/27577718">PubMed Abstract </a> | <a target=xrefwindow id=d2753e3901 href="http://dx.doi.org/10.1016/j.neuroimage.2016.08.056">Publisher Full Text </a> | <a target=xrefwindow id=d2753e3905 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5183471">Free Full Text </a></span></li><li><a name=ref-94 class=n-a></a><span class=label>94. </span>&nbsp;<span class=citation><a name=d2753e3914 class=n-a></a>Heurling K, Leuzy A, Jonasson M, <i> et al.</i>: Quantitative positron emission tomography in brain research. <i>Brain Res.</i> 2017; <b>1670</b>: 220–34. <a target=xrefwindow id=d2753e3925 href="http://www.ncbi.nlm.nih.gov/pubmed/28652218">PubMed Abstract </a> | <a target=xrefwindow id=d2753e3928 href="http://dx.doi.org/10.1016/j.brainres.2017.06.022">Publisher Full Text </a></span></li><li><a name=ref-95 class=n-a></a><span class=label>95. </span>&nbsp;<span class=citation><a name=d2753e3937 class=n-a></a>Lammertsma AA: Forward to the Past: The Case for Quantitative PET Imaging. <i>J Nucl Med.</i> 2017; <b>58</b>(7): 1019–24. <a target=xrefwindow id=d2753e3945 href="http://www.ncbi.nlm.nih.gov/pubmed/28522743">PubMed Abstract </a> | <a target=xrefwindow id=d2753e3948 href="http://dx.doi.org/10.2967/jnumed.116.188029">Publisher Full Text </a></span></li><li><a name=ref-96 class=n-a></a><span class=label>96. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718248469"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2753e3958 class=n-a></a>Doody RS, Thomas RG, Farlow M, <i> et al.</i>: Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease. <i>N Engl J Med.</i> 2014; <b>370</b>(4): 311–21. <a target=xrefwindow id=d2753e3969 href="http://www.ncbi.nlm.nih.gov/pubmed/24450890">PubMed Abstract </a> | <a target=xrefwindow id=d2753e3972 href="http://dx.doi.org/10.1056/NEJMoa1312889">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718248469">F1000 Recommendation</a></span></li><li><a name=ref-97 class=n-a></a><span class=label>97. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718248468"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2753e3985 class=n-a></a>Salloway S, Sperling R, Fox NC, <i> et al.</i>: Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease. <i>N Engl J Med.</i> 2014; <b>370</b>(4): 322–33. <a target=xrefwindow id=d2753e3996 href="http://www.ncbi.nlm.nih.gov/pubmed/24450891">PubMed Abstract </a> | <a target=xrefwindow id=d2753e3999 href="http://dx.doi.org/10.1056/NEJMoa1304839">Publisher Full Text </a> | <a target=xrefwindow id=d2753e4003 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4159618">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718248468">F1000 Recommendation</a></span></li><li><a name=ref-98 class=n-a></a><span class=label>98. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726696119"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2753e4016 class=n-a></a>Sevigny J, Chiao P, Bussière T, <i> et al.</i>: The antibody aducanumab reduces Aβ plaques in Alzheimer's disease. <i>Nature.</i> 2016; <b>537</b>(7618): 50–6. <a target=xrefwindow id=d2753e4027 href="http://www.ncbi.nlm.nih.gov/pubmed/27582220">PubMed Abstract </a> | <a target=xrefwindow id=d2753e4030 href="http://dx.doi.org/10.1038/nature19323">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726696119">F1000 Recommendation</a></span></li><li><a name=ref-99 class=n-a></a><span class=label>99. </span>&nbsp;<span class=citation><a name=d2753e4043 class=n-a></a>Kayed R, Lasagna-Reeves CA: Molecular mechanisms of amyloid oligomers toxicity. <i>J Alzheimers Dis.</i> 2013; <b>33</b> Suppl 1: S67–78. <a target=xrefwindow id=d2753e4051 href="http://www.ncbi.nlm.nih.gov/pubmed/22531422">PubMed Abstract </a> | <a target=xrefwindow id=d2753e4054 href="http://dx.doi.org/10.3233/JAD-2012-129001">Publisher Full Text </a></span></li><li><a name=ref-100 class=n-a></a><span class=label>100. </span>&nbsp;<span class=citation><a name=d2753e4063 class=n-a></a>Haass C, Selkoe DJ: Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. <i>Nat Rev Mol Cell Biol.</i> 2007; <b>8</b>(2): 101–12. <a target=xrefwindow id=d2753e4071 href="http://www.ncbi.nlm.nih.gov/pubmed/17245412">PubMed Abstract </a> | <a target=xrefwindow id=d2753e4074 href="http://dx.doi.org/10.1038/nrm2101">Publisher Full Text </a></span></li><li><a name=ref-101 class=n-a></a><span class=label>101. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717996335"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2753e4083 class=n-a></a>Hedden T, Oh H, Younger AP, <i> et al.</i>: Meta-analysis of amyloid-cognition relations in cognitively normal older adults. <i>Neurology.</i> 2013; <b>80</b>(14): 1341–8. <a target=xrefwindow id=d2753e4094 href="http://www.ncbi.nlm.nih.gov/pubmed/23547267">PubMed Abstract </a> | <a target=xrefwindow id=d2753e4097 href="http://dx.doi.org/10.1212/WNL.0b013e31828ab35d">Publisher Full Text </a> | <a target=xrefwindow id=d2753e4101 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3656457">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717996335">F1000 Recommendation</a></span></li><li><a name=ref-102 class=n-a></a><span class=label>102. </span>&nbsp;<span class=citation><a name=d2753e4115 class=n-a></a>Jack CR Jr, Wiste HJ, Weigand SD, <i> et al.</i>: Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity. <i>Neurology.</i> 2013; <b>81</b>(20): 1732–40. <a target=xrefwindow id=d2753e4126 href="http://www.ncbi.nlm.nih.gov/pubmed/24132377">PubMed Abstract </a> | <a target=xrefwindow id=d2753e4129 href="http://dx.doi.org/10.1212/01.wnl.0000435556.21319.e4">Publisher Full Text </a> | <a target=xrefwindow id=d2753e4133 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3821718">Free Full Text </a></span></li><li><a name=ref-103 class=n-a></a><span class=label>103. </span>&nbsp;<span class=citation><a name=d2753e4142 class=n-a></a>Ossenkoppele R, van der Flier WM, Verfaillie SC, <i> et al.</i>: Long-term effects of amyloid, hypometabolism, and atrophy on neuropsychological functions. <i>Neurology.</i> 2014; <b>82</b>(20): 1768–75. <a target=xrefwindow id=d2753e4153 href="http://www.ncbi.nlm.nih.gov/pubmed/24748672">PubMed Abstract </a> | <a target=xrefwindow id=d2753e4156 href="http://dx.doi.org/10.1212/WNL.0000000000000432">Publisher Full Text </a></span></li><li><a name=ref-104 class=n-a></a><span class=label>104. </span>&nbsp;<span class=citation><a name=d2753e4165 class=n-a></a>Jagust WJ, Landau SM; Alzheimer's Disease Neuroimaging Initiative: Apolipoprotein E, not fibrillar β-amyloid, reduces cerebral glucose metabolism in normal aging. <i>J Neurosci.</i> 2012; <b>32</b>(50): 18227–33. <a target=xrefwindow id=d2753e4173 href="http://www.ncbi.nlm.nih.gov/pubmed/23238736">PubMed Abstract </a> | <a target=xrefwindow id=d2753e4176 href="http://dx.doi.org/10.1523/JNEUROSCI.3266-12.2012">Publisher Full Text </a> | <a target=xrefwindow id=d2753e4179 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3537830">Free Full Text </a></span></li><li><a name=ref-105 class=n-a></a><span class=label>105. </span>&nbsp;<span class=citation><a name=d2753e4188 class=n-a></a>Okamura N, Harada R, Furumoto S, <i> et al.</i>: Tau PET imaging in Alzheimer's disease. <i>Curr Neurol Neurosci Rep.</i> 2014; <b>14</b>(11): 500. <a target=xrefwindow id=d2753e4199 href="http://www.ncbi.nlm.nih.gov/pubmed/25239654">PubMed Abstract </a> | <a target=xrefwindow id=d2753e4202 href="http://dx.doi.org/10.1007/s11910-014-0500-6">Publisher Full Text </a></span></li><li><a name=ref-106 class=n-a></a><span class=label>106. </span>&nbsp;<span class=citation><a name=d2753e4211 class=n-a></a>Villemagne VL, Okamura N: <i>In vivo</i> tau imaging: obstacles and progress. <i>Alzheimers Dement.</i> 2014; <b>10</b>(3 Suppl): S254–64. <a target=xrefwindow id=d2753e4222 href="http://www.ncbi.nlm.nih.gov/pubmed/24924676">PubMed Abstract </a> | <a target=xrefwindow id=d2753e4225 href="http://dx.doi.org/10.1016/j.jalz.2014.04.013">Publisher Full Text </a></span></li><li><a name=ref-107 class=n-a></a><span class=label>107. </span>&nbsp;<span class=citation><a name=d2753e4234 class=n-a></a>Villemagne VL, Okamura N: Tau imaging in the study of ageing, Alzheimer's disease, and other neurodegenerative conditions. <i>Curr Opin Neurobiol.</i> 2016; <b>36</b>: 43–51. <a target=xrefwindow id=d2753e4242 href="http://www.ncbi.nlm.nih.gov/pubmed/26397020">PubMed Abstract </a> | <a target=xrefwindow id=d2753e4245 href="http://dx.doi.org/10.1016/j.conb.2015.09.002">Publisher Full Text </a></span></li><li><a name=ref-108 class=n-a></a><span class=label>108. </span>&nbsp;<span class=citation><a name=d2753e4255 class=n-a></a>Okamura N, Harada R, Furukawa K, <i> et al.</i>: Advances in the development of tau PET radiotracers and their clinical applications. <i>Ageing Res Rev.</i> 2016; <b>30</b>: 107–13. <a target=xrefwindow id=d2753e4266 href="http://www.ncbi.nlm.nih.gov/pubmed/26802556">PubMed Abstract </a> | <a target=xrefwindow id=d2753e4269 href="http://dx.doi.org/10.1016/j.arr.2015.12.010">Publisher Full Text </a></span></li><li><a name=ref-109 class=n-a></a><span class=label>109. </span>&nbsp;<span class=citation><a name=d2753e4278 class=n-a></a>Villemagne VL, Fodero-Tavoletti MT, Masters CL, <i> et al.</i>: Tau imaging: early progress and future directions. <i>Lancet Neurol.</i> 2015; <b>14</b>(1): 114–24. <a target=xrefwindow id=d2753e4289 href="http://www.ncbi.nlm.nih.gov/pubmed/25496902">PubMed Abstract </a> | <a target=xrefwindow id=d2753e4292 href="http://dx.doi.org/10.1016/S1474-4422(14)70252-2">Publisher Full Text </a></span></li><li><a name=ref-110 class=n-a></a><span class=label>110. </span>&nbsp;<span class=citation><a name=d2753e4301 class=n-a></a>Wang Y, Mandelkow E: Tau in physiology and pathology. <i>Nat Rev Neurosci.</i> 2016; <b>17</b>(1): 5–21. <a target=xrefwindow id=d2753e4309 href="http://www.ncbi.nlm.nih.gov/pubmed/26631930">PubMed Abstract </a> | <a target=xrefwindow id=d2753e4312 href="http://dx.doi.org/10.1038/nrn.2015.1">Publisher Full Text </a></span></li><li><a name=ref-111 class=n-a></a><span class=label>111. </span>&nbsp;<span class=citation><a name=d2753e4321 class=n-a></a>Dickson DW, Kouri N, Murray ME, <i> et al.</i>: Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau). <i>J Mol Neurosci.</i> 2011; <b>45</b>(3): 384–9. <a target=xrefwindow id=d2753e4332 href="http://www.ncbi.nlm.nih.gov/pubmed/21720721">PubMed Abstract </a> | <a target=xrefwindow id=d2753e4335 href="http://dx.doi.org/10.1007/s12031-011-9589-0">Publisher Full Text </a> | <a target=xrefwindow id=d2753e4339 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3208128">Free Full Text </a></span></li><li><a name=ref-112 class=n-a></a><span class=label>112. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718329717"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2753e4348 class=n-a></a>Okamura N, Furumoto S, Fodero-Tavoletti MT, <i> et al.</i>: Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using <sup>18</sup>F-THK5105 PET. <i>Brain.</i> 2014; <b>137</b>(Pt 6): 1762–71. <a target=xrefwindow id=d2753e4362 href="http://www.ncbi.nlm.nih.gov/pubmed/24681664">PubMed Abstract </a> | <a target=xrefwindow id=d2753e4366 href="http://dx.doi.org/10.1093/brain/awu064">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718329717">F1000 Recommendation</a></span></li><li><a name=ref-113 class=n-a></a><span class=label>113. </span>&nbsp;<span class=citation><a name=d2753e4379 class=n-a></a>Harada R, Okamura N, Furumoto S, <i> et al.</i>: [<sup>18</sup>F]THK-5117 PET for assessing neurofibrillary pathology in Alzheimer's disease. <i>Eur J Nucl Med Mol Imaging.</i> 2015; <b>42</b>(7): 1052–61. <a target=xrefwindow id=d2753e4393 href="http://www.ncbi.nlm.nih.gov/pubmed/25792456">PubMed Abstract </a> | <a target=xrefwindow id=d2753e4397 href="http://dx.doi.org/10.1007/s00259-015-3035-4">Publisher Full Text </a></span></li><li><a name=ref-114 class=n-a></a><span class=label>114. </span>&nbsp;<span class=citation><a name=d2753e4407 class=n-a></a>Harada R, Okamura N, Furumoto S, <i> et al.</i>: <sup>18</sup>F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease. <i>J Nucl Med.</i> 2016; <b>57</b>(2): 208–14. <a target=xrefwindow id=d2753e4421 href="http://www.ncbi.nlm.nih.gov/pubmed/26541774">PubMed Abstract </a> | <a target=xrefwindow id=d2753e4425 href="http://dx.doi.org/10.2967/jnumed.115.164848">Publisher Full Text </a></span></li><li><a name=ref-115 class=n-a></a><span class=label>115. </span>&nbsp;<span class=citation><a name=d2753e4434 class=n-a></a>Chien DT, Bahri S, Szardenings AK, <i> et al.</i>: Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807. <i>J Alzheimers Dis.</i> 2013; <b>34</b>(2): 457–68. <a target=xrefwindow id=d2753e4445 href="http://www.ncbi.nlm.nih.gov/pubmed/23234879">PubMed Abstract </a> | <a target=xrefwindow id=d2753e4448 href="http://dx.doi.org/10.3233/JAD-122059">Publisher Full Text </a></span></li><li><a name=ref-116 class=n-a></a><span class=label>116. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718113640"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2753e4457 class=n-a></a>Maruyama M, Shimada H, Suhara T, <i> et al.</i>: Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls. <i>Neuron.</i> 2013; <b>79</b>(6): 1094–108. <a target=xrefwindow id=d2753e4468 href="http://www.ncbi.nlm.nih.gov/pubmed/24050400">PubMed Abstract </a> | <a target=xrefwindow id=d2753e4471 href="http://dx.doi.org/10.1016/j.neuron.2013.07.037">Publisher Full Text </a> | <a target=xrefwindow id=d2753e4475 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3809845">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718113640">F1000 Recommendation</a></span></li><li><a name=ref-117 class=n-a></a><span class=label>117. </span>&nbsp;<span class=citation><a name=d2753e4488 class=n-a></a>Cho H, Choi JY, Hwang MS, <i> et al.</i>: Tau PET in Alzheimer disease and mild cognitive impairment. <i>Neurology.</i> 2016; <b>87</b>(4): 375–83. <a target=xrefwindow id=d2753e4499 href="http://www.ncbi.nlm.nih.gov/pubmed/27358341">PubMed Abstract </a> | <a target=xrefwindow id=d2753e4502 href="http://dx.doi.org/10.1212/WNL.0000000000002892">Publisher Full Text </a></span></li><li><a name=ref-118 class=n-a></a><span class=label>118. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725883031"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2753e4511 class=n-a></a>Johnson KA, Schultz A, Betensky RA, <i> et al.</i>: Tau positron emission tomographic imaging in aging and early Alzheimer disease. <i>Ann Neurol.</i> 2016; <b>79</b>(1): 110–9. <a target=xrefwindow id=d2753e4522 href="http://www.ncbi.nlm.nih.gov/pubmed/26505746">PubMed Abstract </a> | <a target=xrefwindow id=d2753e4525 href="http://dx.doi.org/10.1002/ana.24546">Publisher Full Text </a> | <a target=xrefwindow id=d2753e4529 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4738026">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725883031">F1000 Recommendation</a></span></li><li><a name=ref-119 class=n-a></a><span class=label>119. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726209869"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2753e4542 class=n-a></a>Ossenkoppele R, Schonhaut DR, Schöll M, <i> et al.</i>: Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease. <i>Brain.</i> 2016; <b>139</b>(Pt 5): 1551–67. <a target=xrefwindow id=d2753e4553 href="http://www.ncbi.nlm.nih.gov/pubmed/26962052">PubMed Abstract </a> | <a target=xrefwindow id=d2753e4556 href="http://dx.doi.org/10.1093/brain/aww027">Publisher Full Text </a> | <a target=xrefwindow id=d2753e4560 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5006248">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726209869">F1000 Recommendation</a></span></li><li><a name=ref-120 class=n-a></a><span class=label>120. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726190510"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2753e4574 class=n-a></a>Schöll M, Lockhart SN, Schonhaut DR, <i> et al.</i>: PET Imaging of Tau Deposition in the Aging Human Brain. <i>Neuron.</i> 2016; <b>89</b>(5): 971–82. <a target=xrefwindow id=d2753e4585 href="http://www.ncbi.nlm.nih.gov/pubmed/26938442">PubMed Abstract </a> | <a target=xrefwindow id=d2753e4588 href="http://dx.doi.org/10.1016/j.neuron.2016.01.028">Publisher Full Text </a> | <a target=xrefwindow id=d2753e4592 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4779187">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726190510">F1000 Recommendation</a></span></li><li><a name=ref-121 class=n-a></a><span class=label>121. </span>&nbsp;<span class=citation><a name=d2753e4605 class=n-a></a>Nelson PT, Alafuzoff I, Bigio EH, <i> et al.</i>: Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. <i>J Neuropathol Exp Neurol.</i> 2012; <b>71</b>(5): 362–81. <a target=xrefwindow id=d2753e4616 href="http://www.ncbi.nlm.nih.gov/pubmed/22487856">PubMed Abstract </a> | <a target=xrefwindow id=d2753e4619 href="http://dx.doi.org/10.1097/NEN.0b013e31825018f7">Publisher Full Text </a> | <a target=xrefwindow id=d2753e4623 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3560290">Free Full Text </a></span></li><li><a name=ref-122 class=n-a></a><span class=label>122. </span>&nbsp;<span class=citation><a name=d2753e4632 class=n-a></a>Murray ME, Lowe VJ, Graff-Radford NR, <i> et al.</i>: Clinicopathologic and <sup>11</sup>C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum. <i>Brain.</i> 2015; <b>138</b>(Pt 5): 1370–81. <a target=xrefwindow id=d2753e4646 href="http://www.ncbi.nlm.nih.gov/pubmed/25805643">PubMed Abstract </a> | <a target=xrefwindow id=d2753e4650 href="http://dx.doi.org/10.1093/brain/awv050">Publisher Full Text </a> | <a target=xrefwindow id=d2753e4653 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4407190">Free Full Text </a></span></li><li><a name=ref-123 class=n-a></a><span class=label>123. </span>&nbsp;<span class=citation><a name=d2753e4662 class=n-a></a>Schwarz AJ, Yu P, Miller BB, <i> et al.</i>: Regional profiles of the candidate tau PET ligand <sup>18</sup>F-AV-1451 recapitulate key features of Braak histopathological stages. <i>Brain.</i> 2016; <b>139</b>(Pt 5): 1539–50. <a target=xrefwindow id=d2753e4676 href="http://www.ncbi.nlm.nih.gov/pubmed/26936940">PubMed Abstract </a> | <a target=xrefwindow id=d2753e4680 href="http://dx.doi.org/10.1093/brain/aww023">Publisher Full Text </a></span></li><li><a name=ref-124 class=n-a></a><span class=label>124. </span>&nbsp;<span class=citation><a name=d2753e4689 class=n-a></a>Warren JD, Fletcher PD, Golden HL: The paradox of syndromic diversity in Alzheimer disease. <i>Nat Rev Neurol.</i> 2012; <b>8</b>(8): 451–64. <a target=xrefwindow id=d2753e4697 href="http://www.ncbi.nlm.nih.gov/pubmed/22801974">PubMed Abstract </a> | <a target=xrefwindow id=d2753e4700 href="http://dx.doi.org/10.1038/nrneurol.2012.135">Publisher Full Text </a></span></li><li><a name=ref-125 class=n-a></a><span class=label>125. </span>&nbsp;<span class=citation><a name=d2753e4709 class=n-a></a>Ossenkoppele R, Schonhaut DR, Baker SL, <i> et al.</i>: Tau, amyloid, and hypometabolism in a patient with posterior cortical atrophy. <i>Ann Neurol.</i> 2015; <b>77</b>(2): 338–42. <a target=xrefwindow id=d2753e4720 href="http://www.ncbi.nlm.nih.gov/pubmed/25448043">PubMed Abstract </a> | <a target=xrefwindow id=d2753e4723 href="http://dx.doi.org/10.1002/ana.24321">Publisher Full Text </a> | <a target=xrefwindow id=d2753e4727 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4382124">Free Full Text </a></span></li><li><a name=ref-126 class=n-a></a><span class=label>126. </span>&nbsp;<span class=citation><a name=d2753e4737 class=n-a></a>Bischof GN, Jessen F, Fliessbach K, <i> et al.</i>: Impact of tau and amyloid burden on glucose metabolism in Alzheimer's disease. <i>Ann Clin Transl Neurol.</i> 2016; <b>3</b>(12): 934–9. <a target=xrefwindow id=d2753e4748 href="http://www.ncbi.nlm.nih.gov/pubmed/28097205">PubMed Abstract </a> | <a target=xrefwindow id=d2753e4751 href="http://dx.doi.org/10.1002/acn3.339">Publisher Full Text </a> | <a target=xrefwindow id=d2753e4755 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5224823">Free Full Text </a></span></li><li><a name=ref-127 class=n-a></a><span class=label>127. </span>&nbsp;<span class=citation><a name=d2753e4764 class=n-a></a>Xia C, Makaretz SJ, Caso C, <i> et al.</i>: Association of <i>In Vivo</i> [<sup>18</sup>F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer Disease. <i>JAMA Neurol.</i> 2017; <b>74</b>(4): 427–36. <a target=xrefwindow id=d2753e4782 href="http://www.ncbi.nlm.nih.gov/pubmed/28241163">PubMed Abstract </a> | <a target=xrefwindow id=d2753e4785 href="http://dx.doi.org/10.1001/jamaneurol.2016.5755">Publisher Full Text </a> | <a target=xrefwindow id=d2753e4788 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5470368">Free Full Text </a></span></li><li><a name=ref-128 class=n-a></a><span class=label>128. </span>&nbsp;<span class=citation><a name=d2753e4797 class=n-a></a>Selkoe DJ, Hardy J: The amyloid hypothesis of Alzheimer's disease at 25 years. <i>EMBO Mol Med.</i> 2016; <b>8</b>(6): 595–608. <a target=xrefwindow id=d2753e4805 href="http://www.ncbi.nlm.nih.gov/pubmed/27025652">PubMed Abstract </a> | <a target=xrefwindow id=d2753e4808 href="http://dx.doi.org/10.15252/emmm.201606210">Publisher Full Text </a> | <a target=xrefwindow id=d2753e4811 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4888851">Free Full Text </a></span></li><li><a name=ref-129 class=n-a></a><span class=label>129. </span>&nbsp;<span class=citation><a name=d2753e4820 class=n-a></a>Brier MR, Gordon B, Friedrichsen K, <i> et al.</i>: Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease. <i>Sci Transl Med.</i> 2016; <b>8</b>(338): 338ra66. <a target=xrefwindow id=d2753e4831 href="http://www.ncbi.nlm.nih.gov/pubmed/27169802">PubMed Abstract </a> | <a target=xrefwindow id=d2753e4834 href="http://dx.doi.org/10.1126/scitranslmed.aaf2362">Publisher Full Text </a> | <a target=xrefwindow id=d2753e4838 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5267531">Free Full Text </a></span></li><li><a name=ref-130 class=n-a></a><span class=label>130. </span>&nbsp;<span class=citation><a name=d2753e4847 class=n-a></a>Chiotis K, Saint-Aubert L, Savitcheva I, <i> et al.</i>: Imaging <i>in-vivo</i> tau pathology in Alzheimer's disease with THK5317 PET in a multimodal paradigm. <i>Eur J Nucl Med Mol Imaging.</i> 2016; <b>43</b>(9): 1686–99. <a target=xrefwindow id=d2753e4861 href="http://www.ncbi.nlm.nih.gov/pubmed/26996778">PubMed Abstract </a> | <a target=xrefwindow id=d2753e4865 href="http://dx.doi.org/10.1007/s00259-016-3363-z">Publisher Full Text </a> | <a target=xrefwindow id=d2753e4868 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4932128">Free Full Text </a></span></li><li><a name=ref-131 class=n-a></a><span class=label>131. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726435869"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2753e4877 class=n-a></a>Cho H, Choi JY, Hwang MS, <i> et al.</i>: <i>In vivo</i> cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum. <i>Ann Neurol.</i> 2016; <b>80</b>(2): 247–58. <a target=xrefwindow id=d2753e4891 href="http://www.ncbi.nlm.nih.gov/pubmed/27323247">PubMed Abstract </a> | <a target=xrefwindow id=d2753e4895 href="http://dx.doi.org/10.1002/ana.24711">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726435869">F1000 Recommendation</a></span></li><li><a name=ref-132 class=n-a></a><span class=label>132. </span>&nbsp;<span class=citation><a name=d2753e4909 class=n-a></a>Lockhart SN, Schöll M, Baker SL, <i> et al.</i>: Amyloid and tau PET demonstrate region-specific associations in normal older people. <i>Neuroimage.</i> 2017; <b>150</b>: 191–9. <a target=xrefwindow id=d2753e4920 href="http://www.ncbi.nlm.nih.gov/pubmed/28232190">PubMed Abstract </a> | <a target=xrefwindow id=d2753e4923 href="http://dx.doi.org/10.1016/j.neuroimage.2017.02.051">Publisher Full Text </a> | <a target=xrefwindow id=d2753e4927 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5391247">Free Full Text </a></span></li><li><a name=ref-133 class=n-a></a><span class=label>133. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727195707"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2753e4936 class=n-a></a>Pontecorvo MJ, Devous MD Sr, Navitsky M, <i> et al.</i>: Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition. <i>Brain.</i> 2017; <b>140</b>(3): 748–63. <a target=xrefwindow id=d2753e4947 href="http://www.ncbi.nlm.nih.gov/pubmed/28077397">PubMed Abstract </a> | <a target=xrefwindow id=d2753e4950 href="http://dx.doi.org/10.1093/brain/aww334">Publisher Full Text </a> | <a target=xrefwindow id=d2753e4954 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5382945">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727195707">F1000 Recommendation</a></span></li><li><a name=ref-134 class=n-a></a><span class=label>134. </span>&nbsp;<span class=citation><a name=d2753e4967 class=n-a></a>Hanseeuw BJ, Betensky RA, Schultz AP, <i> et al.</i>: Fluorodeoxyglucose metabolism associated with tau-amyloid interaction predicts memory decline. <i>Ann Neurol.</i> 2017; <b>81</b>(4): 583–96. <a target=xrefwindow id=d2753e4978 href="http://www.ncbi.nlm.nih.gov/pubmed/28253546">PubMed Abstract </a> | <a target=xrefwindow id=d2753e4981 href="http://dx.doi.org/10.1002/ana.24910">Publisher Full Text </a> | <a target=xrefwindow id=d2753e4985 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5404378">Free Full Text </a></span></li><li><a name=ref-135 class=n-a></a><span class=label>135. </span>&nbsp;<span class=citation><a name=d2753e4994 class=n-a></a>Vemuri P, Lowe VJ, Knopman DS, <i> et al.</i>: Tau-PET uptake: Regional variation in average SUVR and impact of amyloid deposition. <i>Alzheimers Dement (Amst).</i> 2017; <b>6</b>: 21–30. <a target=xrefwindow id=d2753e5005 href="http://www.ncbi.nlm.nih.gov/pubmed/28138510">PubMed Abstract </a> | <a target=xrefwindow id=d2753e5008 href="http://dx.doi.org/10.1016/j.dadm.2016.12.010">Publisher Full Text </a> | <a target=xrefwindow id=d2753e5012 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5257031">Free Full Text </a></span></li><li><a name=ref-136 class=n-a></a><span class=label>136. </span>&nbsp;<span class=citation><a name=d2753e5021 class=n-a></a>Saint-Aubert L, Lemoine L, Chiotis K, <i> et al.</i>: Tau PET imaging: present and future directions. <i>Mol Neurodegener.</i> 2017; <b>12</b>(1): 19. <a target=xrefwindow id=d2753e5032 href="http://www.ncbi.nlm.nih.gov/pubmed/28219440">PubMed Abstract </a> | <a target=xrefwindow id=d2753e5035 href="http://dx.doi.org/10.1186/s13024-017-0162-3">Publisher Full Text </a> | <a target=xrefwindow id=d2753e5039 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5319037">Free Full Text </a></span></li><li><a name=ref-137 class=n-a></a><span class=label>137. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725773166"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2753e5048 class=n-a></a>Marquié M, Normandin MD, Vanderburg CR, <i> et al.</i>: Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue. <i>Ann Neurol.</i> 2015; <b>78</b>(5): 787–800. <a target=xrefwindow id=d2753e5059 href="http://www.ncbi.nlm.nih.gov/pubmed/26344059">PubMed Abstract </a> | <a target=xrefwindow id=d2753e5062 href="http://dx.doi.org/10.1002/ana.24517">Publisher Full Text </a> | <a target=xrefwindow id=d2753e5066 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4900162">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725773166">F1000 Recommendation</a></span></li><li><a name=ref-138 class=n-a></a><span class=label>138. </span>&nbsp;<span class=citation><a name=d2753e5080 class=n-a></a>Lowe VJ, Curran G, Fang P, <i> et al.</i>: An autoradiographic evaluation of AV-1451 Tau PET in dementia. <i>Acta Neuropathol Commun.</i> 2016; <b>4</b>(1): 58. <a target=xrefwindow id=d2753e5091 href="http://www.ncbi.nlm.nih.gov/pubmed/27296779">PubMed Abstract </a> | <a target=xrefwindow id=d2753e5094 href="http://dx.doi.org/10.1186/s40478-016-0315-6">Publisher Full Text </a> | <a target=xrefwindow id=d2753e5098 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4906968">Free Full Text </a></span></li><li><a name=ref-139 class=n-a></a><span class=label>139. </span>&nbsp;<span class=citation><a name=d2753e5107 class=n-a></a>Josephs KA, Whitwell JL, Tacik P, <i> et al.</i>: [<sup>18</sup>F]AV-1451 tau-PET uptake does correlate with quantitatively measured 4R-tau burden in autopsy-confirmed corticobasal degeneration. <i>Acta Neuropathol.</i> 2016; <b>132</b>(6): 931–3. <a target=xrefwindow id=d2753e5121 href="http://www.ncbi.nlm.nih.gov/pubmed/27645292">PubMed Abstract </a> | <a target=xrefwindow id=d2753e5125 href="http://dx.doi.org/10.1007/s00401-016-1618-1">Publisher Full Text </a> | <a target=xrefwindow id=d2753e5128 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5107140">Free Full Text </a></span></li><li><a name=ref-140 class=n-a></a><span class=label>140. </span>&nbsp;<span class=citation><a name=d2753e5137 class=n-a></a>Kikuchi A, Okamura N, Hasegawa T, <i> et al.</i>: <i>In vivo</i> visualization of tau deposits in corticobasal syndrome by <sup>18</sup>F-THK5351 PET. <i>Neurology.</i> 2016; <b>87</b>(22): 2309–16. <a target=xrefwindow id=d2753e5155 href="http://www.ncbi.nlm.nih.gov/pubmed/27794115">PubMed Abstract </a> | <a target=xrefwindow id=d2753e5158 href="http://dx.doi.org/10.1212/WNL.0000000000003375">Publisher Full Text </a> | <a target=xrefwindow id=d2753e5161 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5135024">Free Full Text </a></span></li><li><a name=ref-141 class=n-a></a><span class=label>141. </span>&nbsp;<span class=citation><a name=d2753e5170 class=n-a></a>Sander K, Lashley T, Gami P, <i> et al.</i>: Characterization of tau positron emission tomography tracer [<sup>18</sup>F]AV-1451 binding to postmortem tissue in Alzheimer's disease, primary tauopathies, and other dementias. <i>Alzheimers Dement.</i> 2016; <b>12</b>(11): 1116–24. <a target=xrefwindow id=d2753e5184 href="http://www.ncbi.nlm.nih.gov/pubmed/26892233">PubMed Abstract </a> | <a target=xrefwindow id=d2753e5188 href="http://dx.doi.org/10.1016/j.jalz.2016.01.003">Publisher Full Text </a></span></li><li><a name=ref-142 class=n-a></a><span class=label>142. </span>&nbsp;<span class=citation><a name=d2753e5197 class=n-a></a>Ishiki A, Harada R, Okamura N, <i> et al.</i>: Tau imaging with [<sup>18</sup> F]THK-5351 in progressive supranuclear palsy. <i>Eur J Neurol.</i> 2017; <b>24</b>(1): 130–6. <a target=xrefwindow id=d2753e5211 href="http://www.ncbi.nlm.nih.gov/pubmed/27797445">PubMed Abstract </a> | <a target=xrefwindow id=d2753e5215 href="http://dx.doi.org/10.1111/ene.13164">Publisher Full Text </a></span></li><li><a name=ref-143 class=n-a></a><span class=label>143. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727469372"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2753e5224 class=n-a></a>Ng KP, Pascoal TA, Mathotaarachchi S, <i> et al.</i>: Monoamine oxidase B inhibitor, selegiline, reduces <sup>18</sup>F-THK5351 uptake in the human brain. <i>Alzheimers Res Ther.</i> 2017; <b>9</b>(1): 25. <a target=xrefwindow id=d2753e5238 href="http://www.ncbi.nlm.nih.gov/pubmed/28359327">PubMed Abstract </a> | <a target=xrefwindow id=d2753e5242 href="http://dx.doi.org/10.1186/s13195-017-0253-y">Publisher Full Text </a> | <a target=xrefwindow id=d2753e5245 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5374697">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727469372">F1000 Recommendation</a></span></li><li><a name=ref-144 class=n-a></a><span class=label>144. </span>&nbsp;<span class=citation><a name=d2753e5259 class=n-a></a>Hostetler ED, Walji AM, Zeng Z, <i> et al.</i>: Preclinical Characterization of <sup>18</sup>F-MK-6240, a Promising PET Tracer for <i>In Vivo</i> Quantification of Human Neurofibrillary Tangles. <i>J Nucl Med.</i> 2016; <b>57</b>(10): 1599–606. <a target=xrefwindow id=d2753e5277 href="http://www.ncbi.nlm.nih.gov/pubmed/27230925">PubMed Abstract </a> | <a target=xrefwindow id=d2753e5280 href="http://dx.doi.org/10.2967/jnumed.115.171678">Publisher Full Text </a></span></li><li><a name=ref-145 class=n-a></a><span class=label>145. </span>&nbsp;<span class=citation><a name=d2753e5289 class=n-a></a>Xia CF, Arteaga J, Chen G, <i> et al.</i>: [<sup>18</sup>F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease. <i>Alzheimers Dement.</i> 2013; <b>9</b>(6): 666–76. <a target=xrefwindow id=d2753e5303 href="http://www.ncbi.nlm.nih.gov/pubmed/23411393">PubMed Abstract </a> | <a target=xrefwindow id=d2753e5307 href="http://dx.doi.org/10.1016/j.jalz.2012.11.008">Publisher Full Text </a></span></li><li><a name=ref-146 class=n-a></a><span class=label>146. </span>&nbsp;<span class=citation><a name=d2753e5316 class=n-a></a>Barret O, Alagille D, Sanabria S, <i> et al.</i>: Kinetic Modeling of the Tau PET Tracer <sup>18</sup>F-AV-1451 in Human Healthy Volunteers and Alzheimer Disease Subjects. <i>J Nucl Med.</i> 2017; <b>58</b>(7): 1124–31. <a target=xrefwindow id=d2753e5330 href="http://www.ncbi.nlm.nih.gov/pubmed/27908967">PubMed Abstract </a> | <a target=xrefwindow id=d2753e5334 href="http://dx.doi.org/10.2967/jnumed.116.182881">Publisher Full Text </a></span></li><li><a name=ref-147 class=n-a></a><span class=label>147. </span>&nbsp;<span class=citation><a name=d2753e5343 class=n-a></a>Jacobs AH, Tavitian B; INMiND consortium, Noninvasive molecular imaging of neuroinflammation. <i>J Cereb Blood Flow Metab.</i> 2012; <b>32</b>(7): 1393–415. <a target=xrefwindow id=d2753e5351 href="http://www.ncbi.nlm.nih.gov/pubmed/22549622">PubMed Abstract </a> | <a target=xrefwindow id=d2753e5354 href="http://dx.doi.org/10.1038/jcbfm.2012.53">Publisher Full Text </a> | <a target=xrefwindow id=d2753e5357 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3390799">Free Full Text </a></span></li><li><a name=ref-148 class=n-a></a><span class=label>148. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725413893"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2753e5366 class=n-a></a>Heneka MT, Carson MJ, El Khoury J, <i> et al.</i>: Neuroinflammation in Alzheimer's disease. <i>Lancet Neurol.</i> 2015; <b>14</b>(4): 388–405. <a target=xrefwindow id=d2753e5377 href="http://www.ncbi.nlm.nih.gov/pubmed/25792098">PubMed Abstract </a> | <a target=xrefwindow id=d2753e5380 href="http://dx.doi.org/10.1016/S1474-4422(15)70016-5">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725413893">F1000 Recommendation</a></span></li><li><a name=ref-149 class=n-a></a><span class=label>149. </span>&nbsp;<span class=citation><a name=d2753e5393 class=n-a></a>Ransohoff RM: How neuroinflammation contributes to neurodegeneration. <i>Science.</i> 2016; <b>353</b>(6301): 777–83. <a target=xrefwindow id=d2753e5401 href="http://www.ncbi.nlm.nih.gov/pubmed/27540165">PubMed Abstract </a> | <a target=xrefwindow id=d2753e5404 href="http://dx.doi.org/10.1126/science.aag2590">Publisher Full Text </a></span></li><li><a name=ref-150 class=n-a></a><span class=label>150. </span>&nbsp;<span class=citation><a name=d2753e5414 class=n-a></a>Fowler JS, Logan J, Volkow ND, <i> et al.</i>: Translational neuroimaging: positron emission tomography studies of monoamine oxidase. <i>Mol Imaging Biol.</i> 2005; <b>7</b>(6): 377–87. <a target=xrefwindow id=d2753e5425 href="http://www.ncbi.nlm.nih.gov/pubmed/16265597">PubMed Abstract </a> | <a target=xrefwindow id=d2753e5428 href="http://dx.doi.org/10.1007/s11307-005-0016-1">Publisher Full Text </a></span></li><li><a name=ref-151 class=n-a></a><span class=label>151. </span>&nbsp;<span class=citation><a name=d2753e5437 class=n-a></a>Venneti S, Lopresti BJ, Wiley CA: The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: from pathology to imaging. <i>Prog Neurobiol.</i> 2006; <b>80</b>(6): 308–22. <a target=xrefwindow id=d2753e5445 href="http://www.ncbi.nlm.nih.gov/pubmed/17156911">PubMed Abstract </a> | <a target=xrefwindow id=d2753e5448 href="http://dx.doi.org/10.1016/j.pneurobio.2006.10.002">Publisher Full Text </a> | <a target=xrefwindow id=d2753e5451 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1849976">Free Full Text </a></span></li><li><a name=ref-152 class=n-a></a><span class=label>152. </span>&nbsp;<span class=citation><a name=d2753e5460 class=n-a></a>Liu GJ, Middleton RJ, Hatty CR, <i> et al.</i>: The 18 kDa translocator protein, microglia and neuroinflammation. <i>Brain Pathol.</i> 2014; <b>24</b>(6): 631–53. <a target=xrefwindow id=d2753e5471 href="http://www.ncbi.nlm.nih.gov/pubmed/25345894">PubMed Abstract </a> | <a target=xrefwindow id=d2753e5474 href="http://dx.doi.org/10.1111/bpa.12196">Publisher Full Text </a></span></li><li><a name=ref-153 class=n-a></a><span class=label>153. </span>&nbsp;<span class=citation><a name=d2753e5483 class=n-a></a>Chauveau F, Boutin H, Van Camp N, <i> et al.</i>: Nuclear imaging of neuroinflammation: a comprehensive review of [<sup>11</sup>C]PK11195 challengers. <i>Eur J Nucl Med Mol Imaging.</i> 2008; <b>35</b>(12): 2304–19. <a target=xrefwindow id=d2753e5497 href="http://www.ncbi.nlm.nih.gov/pubmed/18828015">PubMed Abstract </a> | <a target=xrefwindow id=d2753e5501 href="http://dx.doi.org/10.1007/s00259-008-0908-9">Publisher Full Text </a></span></li><li><a name=ref-154 class=n-a></a><span class=label>154. </span>&nbsp;<span class=citation><a name=d2753e5510 class=n-a></a>Schain M, Kreisl WC: Neuroinflammation in Neurodegenerative Disorders-a Review. <i>Curr Neurol Neurosci Rep.</i> 2017; <b>17</b>(3): 25. <a target=xrefwindow id=d2753e5518 href="http://www.ncbi.nlm.nih.gov/pubmed/28283959">PubMed Abstract </a> | <a target=xrefwindow id=d2753e5521 href="http://dx.doi.org/10.1007/s11910-017-0733-2">Publisher Full Text </a></span></li><li><a name=ref-155 class=n-a></a><span class=label>155. </span>&nbsp;<span class=citation><a name=d2753e5530 class=n-a></a>Dupont AC, Largeau B, Santiago Ribeiro MJ, <i> et al.</i>: Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases. <i>Int J Mol Sci.</i> 2017; <b>18</b>(4): pii: E785. <a target=xrefwindow id=d2753e5541 href="http://www.ncbi.nlm.nih.gov/pubmed/28387722">PubMed Abstract </a> | <a target=xrefwindow id=d2753e5544 href="http://dx.doi.org/10.3390/ijms18040785">Publisher Full Text </a> | <a target=xrefwindow id=d2753e5548 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5412369">Free Full Text </a></span></li><li><a name=ref-156 class=n-a></a><span class=label>156. </span>&nbsp;<span class=citation><a name=d2753e5558 class=n-a></a>Owen DR, Howell OW, Tang SP, <i> et al.</i>: Two binding sites for [<sup>3</sup>H]PBR28 in human brain: implications for TSPO PET imaging of neuroinflammation. <i>J Cereb Blood Flow Metab.</i> 2010; <b>30</b>(9): 1608–18. <a target=xrefwindow id=d2753e5572 href="http://www.ncbi.nlm.nih.gov/pubmed/20424634">PubMed Abstract </a> | <a target=xrefwindow id=d2753e5576 href="http://dx.doi.org/10.1038/jcbfm.2010.63">Publisher Full Text </a> | <a target=xrefwindow id=d2753e5579 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2949260">Free Full Text </a></span></li><li><a name=ref-157 class=n-a></a><span class=label>157. </span>&nbsp;<span class=citation><a name=d2753e5588 class=n-a></a>Owen DR, Yeo AJ, Gunn RN, <i> et al.</i>: An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28. <i>J Cereb Blood Flow Metab.</i> 2012; <b>32</b>(1): 1–5. <a target=xrefwindow id=d2753e5599 href="http://www.ncbi.nlm.nih.gov/pubmed/22008728">PubMed Abstract </a> | <a target=xrefwindow id=d2753e5602 href="http://dx.doi.org/10.1038/jcbfm.2011.147">Publisher Full Text </a> | <a target=xrefwindow id=d2753e5606 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3323305">Free Full Text </a></span></li><li><a name=ref-158 class=n-a></a><span class=label>158. </span>&nbsp;<span class=citation><a name=d2753e5615 class=n-a></a>Fan Z, Calsolaro V, Atkinson RA, <i> et al.</i>: Flutriciclamide (<sup>18</sup>F-GE180) PET: First-in-Human PET Study of Novel Third-Generation <i>In Vivo</i> Marker of Human Translocator Protein. <i>J Nucl Med.</i> 2016; <b>57</b>(11): 1753–9. <a target=xrefwindow id=d2753e5633 href="http://www.ncbi.nlm.nih.gov/pubmed/27261523">PubMed Abstract </a> | <a target=xrefwindow id=d2753e5636 href="http://dx.doi.org/10.2967/jnumed.115.169078">Publisher Full Text </a></span></li><li><a name=ref-159 class=n-a></a><span class=label>159. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/730624735"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2753e5645 class=n-a></a>Turkheimer FE, Rizzo G, Bloomfield PS, <i> et al.</i>: The methodology of TSPO imaging with positron emission tomography. <i>Biochem Soc Trans.</i> 2015; <b>43</b>(4): 586–92. <a target=xrefwindow id=d2753e5656 href="http://www.ncbi.nlm.nih.gov/pubmed/26551697">PubMed Abstract </a> | <a target=xrefwindow id=d2753e5659 href="http://dx.doi.org/10.1042/BST20150058">Publisher Full Text </a> | <a target=xrefwindow id=d2753e5663 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4613512">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/730624735">F1000 Recommendation</a></span></li><li><a name=ref-160 class=n-a></a><span class=label>160. </span>&nbsp;<span class=citation><a name=d2753e5676 class=n-a></a>Turkheimer FE, Edison P, Pavese N, <i> et al.</i>: Reference and target region modeling of [<sup>11</sup>C]-(<i>R</i>)-PK11195 brain studies. <i>J Nucl Med.</i> 2007; <b>48</b>(1): 158–67. <a target=xrefwindow id=d2753e5694 href="http://www.ncbi.nlm.nih.gov/pubmed/17204713">PubMed Abstract </a></span></li><li><a name=ref-161 class=n-a></a><span class=label>161. </span>&nbsp;<span class=citation><a name=d2753e5703 class=n-a></a>Yaqub M, van Berckel BN, Schuitemaker A, <i> et al.</i>: Optimization of supervised cluster analysis for extracting reference tissue input curves in (<i>R</i>)-[<sup>11</sup>C]PK11195 brain PET studies. <i>J Cereb Blood Flow Metab.</i> 2012; <b>32</b>(8): 1600–8. <a target=xrefwindow id=d2753e5721 href="http://www.ncbi.nlm.nih.gov/pubmed/22588187">PubMed Abstract </a> | <a target=xrefwindow id=d2753e5724 href="http://dx.doi.org/10.1038/jcbfm.2012.59">Publisher Full Text </a> | <a target=xrefwindow id=d2753e5727 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3421099">Free Full Text </a></span></li><li><a name=ref-162 class=n-a></a><span class=label>162. </span>&nbsp;<span class=citation><a name=d2753e5737 class=n-a></a>Presotto L, Iaccarino L, Bettinardi V, <i> et al.</i>: An automated clustering algorithm for reference region extraction of brain <sup>11</sup>C-PK11195 studies. In: <i>2015 IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC).</i> San Diego, CA, USA. 1–3. <a target=xrefwindow id=d2753e5748 href="http://dx.doi.org/10.1109/NSSMIC.2015.7582180">Publisher Full Text </a></span></li><li><a name=ref-163 class=n-a></a><span class=label>163. </span>&nbsp;<span class=citation><a name=d2753e5757 class=n-a></a>Stefaniak J, O'Brien J: Imaging of neuroinflammation in dementia: a review. <i>J Neurol Neurosurg Psychiatr.</i> 2016; <b>87</b>(1): 21–8. <a target=xrefwindow id=d2753e5765 href="http://www.ncbi.nlm.nih.gov/pubmed/26384512">PubMed Abstract </a> | <a target=xrefwindow id=d2753e5768 href="http://dx.doi.org/10.1136/jnnp-2015-311336">Publisher Full Text </a></span></li><li><a name=ref-164 class=n-a></a><span class=label>164. </span>&nbsp;<span class=citation><a name=d2753e5777 class=n-a></a>Hamelin L, Lagarde J, Dorothée G, <i> et al.</i>: Early and protective microglial activation in Alzheimer's disease: a prospective study using <sup>18</sup>F-DPA-714 PET imaging. <i>Brain.</i> 2016; <b>139</b>(Pt 4): 1252–64. <a target=xrefwindow id=d2753e5791 href="http://www.ncbi.nlm.nih.gov/pubmed/26984188">PubMed Abstract </a> | <a target=xrefwindow id=d2753e5795 href="http://dx.doi.org/10.1093/brain/aww017">Publisher Full Text </a></span></li><li><a name=ref-165 class=n-a></a><span class=label>165. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726105916"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2753e5804 class=n-a></a>Rodriguez-Vieitez E, Saint-Aubert L, Carter SF, <i> et al.</i>: Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease. <i>Brain.</i> 2016; <b>139</b>(Pt 3): 922–36. <a target=xrefwindow id=d2753e5815 href="http://www.ncbi.nlm.nih.gov/pubmed/26813969">PubMed Abstract </a> | <a target=xrefwindow id=d2753e5818 href="http://dx.doi.org/10.1093/brain/awv404">Publisher Full Text </a> | <a target=xrefwindow id=d2753e5822 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4766380">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726105916">F1000 Recommendation</a></span></li><li><a name=ref-166 class=n-a></a><span class=label>166. </span>&nbsp;<span class=citation><a name=d2753e5835 class=n-a></a>Kreisl WC, Lyoo CH, Liow JC, <i> et al.</i>: <sup>11</sup>C-PBR28 binding to translocator protein increases with progression of Alzheimer's disease. <i>Neurobiol Aging.</i> 2016; <b>44</b>: 53–61. <a target=xrefwindow id=d2753e5849 href="http://www.ncbi.nlm.nih.gov/pubmed/27318133">PubMed Abstract </a> | <a target=xrefwindow id=d2753e5853 href="http://dx.doi.org/10.1016/j.neurobiolaging.2016.04.011">Publisher Full Text </a> | <a target=xrefwindow id=d2753e5856 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4939713">Free Full Text </a></span></li><li><a name=ref-167 class=n-a></a><span class=label>167. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/13605956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2753e5865 class=n-a></a>Carter SF, Schöll M, Almkvist O, <i> et al.</i>: Evidence for astrocytosis in prodromal Alzheimer disease provided by <sup>11</sup>C-deuterium-L-deprenyl: a multitracer PET paradigm combining <sup>11</sup>C-Pittsburgh compound B and <sup>18</sup>F-FDG. <i>J Nucl Med.</i> 2012; <b>53</b>(1): 37–46. <a target=xrefwindow id=d2753e5886 href="http://www.ncbi.nlm.nih.gov/pubmed/22213821">PubMed Abstract </a> | <a target=xrefwindow id=d2753e5889 href="http://dx.doi.org/10.2967/jnumed.110.087031">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/13605956">F1000 Recommendation</a></span></li><li><a name=ref-168 class=n-a></a><span class=label>168. </span>&nbsp;<span class=citation><a name=d2753e5903 class=n-a></a>Edison P, Archer HA, Gerhard A, <i> et al.</i>: Microglia, amyloid, and cognition in Alzheimer's disease: An [<sup>11</sup>C](R)PK11195-PET and [<sup>11</sup>C]PIB-PET study. <i>Neurobiol Dis.</i> 2008; <b>32</b>(3): 412–9. <a target=xrefwindow id=d2753e5921 href="http://www.ncbi.nlm.nih.gov/pubmed/18786637">PubMed Abstract </a> | <a target=xrefwindow id=d2753e5924 href="http://dx.doi.org/10.1016/j.nbd.2008.08.001">Publisher Full Text </a></span></li><li><a name=ref-169 class=n-a></a><span class=label>169. </span>&nbsp;<span class=citation><a name=d2753e5933 class=n-a></a>Wiley CA, Lopresti BJ, Venneti S, <i> et al.</i>: Carbon 11-labeled Pittsburgh Compound B and carbon 11-labeled (R)-PK11195 positron emission tomographic imaging in Alzheimer disease. <i>Arch Neurol.</i> 2009; <b>66</b>(1): 60–7. <a target=xrefwindow id=d2753e5944 href="http://www.ncbi.nlm.nih.gov/pubmed/19139300">PubMed Abstract </a> | <a target=xrefwindow id=d2753e5947 href="http://dx.doi.org/10.1001/archneurol.2008.511">Publisher Full Text </a> | <a target=xrefwindow id=d2753e5951 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2666881">Free Full Text </a></span></li><li><a name=ref-170 class=n-a></a><span class=label>170. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/10053957"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2753e5960 class=n-a></a>Yokokura M, Mori N, Yagi S, <i> et al.</i>: <i>In vivo</i> changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer's disease. <i>Eur J Nucl Med Mol Imaging.</i> 2011; <b>38</b>(2): 343–51. <a target=xrefwindow id=d2753e5974 href="http://www.ncbi.nlm.nih.gov/pubmed/20844871">PubMed Abstract </a> | <a target=xrefwindow id=d2753e5978 href="http://dx.doi.org/10.1007/s00259-010-1612-0">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/10053957">F1000 Recommendation</a></span></li><li><a name=ref-171 class=n-a></a><span class=label>171. </span>&nbsp;<span class=citation><a name=d2753e5991 class=n-a></a>Fan Z, Okello AA, Brooks DJ, <i> et al.</i>: Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer's disease. <i>Brain.</i> 2015; <b>138</b>(Pt 12): 3685–98. <a target=xrefwindow id=d2753e6002 href="http://www.ncbi.nlm.nih.gov/pubmed/26510952">PubMed Abstract </a> | <a target=xrefwindow id=d2753e6005 href="http://dx.doi.org/10.1093/brain/awv288">Publisher Full Text </a></span></li><li><a name=ref-172 class=n-a></a><span class=label>172. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727243110"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2753e6014 class=n-a></a>Fan Z, Brooks DJ, Okello A, <i> et al.</i>: An early and late peak in microglial activation in Alzheimer's disease trajectory. <i>Brain.</i> 2017; <b>140</b>(3): 792–803. <a target=xrefwindow id=d2753e6025 href="http://www.ncbi.nlm.nih.gov/pubmed/28122877">PubMed Abstract </a> | <a target=xrefwindow id=d2753e6028 href="http://dx.doi.org/10.1093/brain/aww349">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727243110">F1000 Recommendation</a></span></li><li><a name=ref-173 class=n-a></a><span class=label>173. </span>&nbsp;<span class=citation><a name=d2753e6041 class=n-a></a>Gerhard A, Pavese N, Hotton G, <i> et al.</i>: <i>In vivo</i> imaging of microglial activation with [<sup>11</sup>C](<i>R</i>)-PK11195 PET in idiopathic Parkinson's disease. <i>Neurobiol Dis.</i> 2006; <b>21</b>(2): 404–12. <a target=xrefwindow id=d2753e6062 href="http://www.ncbi.nlm.nih.gov/pubmed/16182554">PubMed Abstract </a> | <a target=xrefwindow id=d2753e6065 href="http://dx.doi.org/10.1016/j.nbd.2005.08.002">Publisher Full Text </a></span></li><li><a name=ref-174 class=n-a></a><span class=label>174. </span>&nbsp;<span class=citation><a name=d2753e6075 class=n-a></a>Iannaccone S, Cerami C, Alessio M, <i> et al.</i>: <i>In vivo</i> microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's disease. <i>Parkinsonism Relat Disord.</i> 2013; <b>19</b>(1): 47–52. <a target=xrefwindow id=d2753e6089 href="http://www.ncbi.nlm.nih.gov/pubmed/22841687">PubMed Abstract </a> | <a target=xrefwindow id=d2753e6093 href="http://dx.doi.org/10.1016/j.parkreldis.2012.07.002">Publisher Full Text </a></span></li><li><a name=ref-175 class=n-a></a><span class=label>175. </span>&nbsp;<span class=citation><a name=d2753e6102 class=n-a></a>Fan Z, Aman Y, Ahmed I, <i> et al.</i>: Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia. <i>Alzheimers Dement.</i> 2015; <b>11</b>(6): 608–21.e7. <a target=xrefwindow id=d2753e6113 href="http://www.ncbi.nlm.nih.gov/pubmed/25239737">PubMed Abstract </a> | <a target=xrefwindow id=d2753e6116 href="http://dx.doi.org/10.1016/j.jalz.2014.06.016">Publisher Full Text </a></span></li><li><a name=ref-176 class=n-a></a><span class=label>176. </span>&nbsp;<span class=citation><a name=d2753e6125 class=n-a></a>Cagnin A, Rossor M, Sampson EL, <i> et al.</i>: <i>In vivo</i> detection of microglial activation in frontotemporal dementia. <i>Ann Neurol.</i> 2004; <b>56</b>(6): 894–7. <a target=xrefwindow id=d2753e6139 href="http://www.ncbi.nlm.nih.gov/pubmed/15562429">PubMed Abstract </a> | <a target=xrefwindow id=d2753e6143 href="http://dx.doi.org/10.1002/ana.20332">Publisher Full Text </a></span></li><li><a name=ref-177 class=n-a></a><span class=label>177. </span>&nbsp;<span class=citation><a name=d2753e6152 class=n-a></a>Gerhard A, Banati RB, Goerres GB, <i> et al.</i>: [<sup>11</sup>C](<i>R</i>)-PK11195 PET imaging of microglial activation in multiple system atrophy. <i>Neurology.</i> 2003; <b>61</b>(5): 686–9. <a target=xrefwindow id=d2753e6170 href="http://www.ncbi.nlm.nih.gov/pubmed/12963764">PubMed Abstract </a> | <a target=xrefwindow id=d2753e6173 href="http://dx.doi.org/10.1212/01.WNL.0000078192.95645.E6">Publisher Full Text </a></span></li><li><a name=ref-178 class=n-a></a><span class=label>178. </span>&nbsp;<span class=citation><a name=d2753e6182 class=n-a></a>Gerhard A, Watts J, Trender-Gerhard I, <i> et al.</i>: <i>In vivo</i> imaging of microglial activation with [<sup>11</sup>C](<i>R</i>)-PK11195 PET in corticobasal degeneration. <i>Mov Disord.</i> 2004; <b>19</b>(10): 1221–6. <a target=xrefwindow id=d2753e6203 href="http://www.ncbi.nlm.nih.gov/pubmed/15390000">PubMed Abstract </a> | <a target=xrefwindow id=d2753e6206 href="http://dx.doi.org/10.1002/mds.20162">Publisher Full Text </a></span></li><li><a name=ref-179 class=n-a></a><span class=label>179. </span>&nbsp;<span class=citation><a name=d2753e6215 class=n-a></a>Gerhard A, Trender-Gerhard I, Turkheimer F, <i> et al.</i>: <i>In vivo</i> imaging of microglial activation with [<sup>11</sup>C](R)-PK11195 PET in progressive supranuclear palsy. <i>Mov Disord.</i> 2006; <b>21</b>(1): 89–93. <a target=xrefwindow id=d2753e6233 href="http://www.ncbi.nlm.nih.gov/pubmed/16108021">PubMed Abstract </a> | <a target=xrefwindow id=d2753e6236 href="http://dx.doi.org/10.1002/mds.20668">Publisher Full Text </a></span></li><li><a name=ref-180 class=n-a></a><span class=label>180. </span>&nbsp;<span class=citation><a name=d2753e6246 class=n-a></a>Iaccarino L, Moresco RM, Presotto L, <i> et al.</i>: An <i>In vivo</i> <sup>11</sup>C-(R)-PK11195 PET and <i>In Vitro</i> Pathology Study of Microglia Activation in Creutzfeldt-Jakob Disease. <i>Mol Neurobiol.</i> 2017; 1–13. <a target=xrefwindow id=d2753e6264 href="http://www.ncbi.nlm.nih.gov/pubmed/28455699">PubMed Abstract </a> | <a target=xrefwindow id=d2753e6267 href="http://dx.doi.org/10.1007/s12035-017-0522-6">Publisher Full Text </a></span></li><li><a name=ref-181 class=n-a></a><span class=label>181. </span>&nbsp;<span class=citation><a name=d2753e6276 class=n-a></a>Hanisch UK, Kettenmann H: Microglia: active sensor and versatile effector cells in the normal and pathologic brain. <i>Nat Neurosci.</i> 2007; <b>10</b>(11): 1387–94. <a target=xrefwindow id=d2753e6284 href="http://www.ncbi.nlm.nih.gov/pubmed/17965659">PubMed Abstract </a> | <a target=xrefwindow id=d2753e6287 href="http://dx.doi.org/10.1038/nn1997">Publisher Full Text </a></span></li><li><a name=ref-182 class=n-a></a><span class=label>182. </span>&nbsp;<span class=citation><a name=d2753e6296 class=n-a></a>Gut P, Zweckstetter M, Banati RB: Lost in translocation: the functions of the 18-kD translocator protein. <i>Trends Endocrinol Metab.</i> 2015; <b>26</b>(7): 349–56. <a target=xrefwindow id=d2753e6304 href="http://www.ncbi.nlm.nih.gov/pubmed/26026242">PubMed Abstract </a> | <a target=xrefwindow id=d2753e6307 href="http://dx.doi.org/10.1016/j.tem.2015.04.001">Publisher Full Text </a></span></li><li><a name=ref-183 class=n-a></a><span class=label>183. </span>&nbsp;<span class=citation><a name=d2753e6316 class=n-a></a>Selvaraj V, Stocco DM: The changing landscape in translocator protein (TSPO) function. <i>Trends Endocrinol Metab.</i> 2015; <b>26</b>(7): 341–8. <a target=xrefwindow id=d2753e6324 href="http://www.ncbi.nlm.nih.gov/pubmed/25801473">PubMed Abstract </a> | <a target=xrefwindow id=d2753e6327 href="http://dx.doi.org/10.1016/j.tem.2015.02.007">Publisher Full Text </a></span></li><li><a name=ref-184 class=n-a></a><span class=label>184. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725613003"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2753e6336 class=n-a></a>Jucaite A, Svenningsson P, Rinne JO, <i> et al.</i>: Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson's disease. <i>Brain.</i> 2015; <b>138</b>(Pt 9): 2687–700. <a target=xrefwindow id=d2753e6347 href="http://www.ncbi.nlm.nih.gov/pubmed/26137956">PubMed Abstract </a> | <a target=xrefwindow id=d2753e6350 href="http://dx.doi.org/10.1093/brain/awv184">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725613003">F1000 Recommendation</a></span></li><li><a name=ref-185 class=n-a></a><span class=label>185. </span>&nbsp;<span class=citation><a name=d2753e6363 class=n-a></a>Dodel R, Spottke A, Gerhard A, <i> et al.</i>: Minocycline 1-year therapy in multiple-system-atrophy: effect on clinical symptoms and [<sup>11</sup>C] (<i>R</i>)-PK11195 PET (MEMSA-trial). <i>Mov Disord.</i> 2010; <b>25</b>(1): 97–107. <a target=xrefwindow id=d2753e6381 href="http://www.ncbi.nlm.nih.gov/pubmed/20014118">PubMed Abstract </a> | <a target=xrefwindow id=d2753e6384 href="http://dx.doi.org/10.1002/mds.22732">Publisher Full Text </a></span></li><li><a name=ref-186 class=n-a></a><span class=label>186. </span>&nbsp;<span class=citation><a name=d2753e6394 class=n-a></a>Ratchford JN, Endres CJ, Hammoud DA, <i> et al.</i>: Decreased microglial activation in MS patients treated with glatiramer acetate. <i>J Neurol.</i> 2012; <b>259</b>(6): 1199–205. <a target=xrefwindow id=d2753e6405 href="http://www.ncbi.nlm.nih.gov/pubmed/22160466">PubMed Abstract </a> | <a target=xrefwindow id=d2753e6408 href="http://dx.doi.org/10.1007/s00415-011-6337-x">Publisher Full Text </a> | <a target=xrefwindow id=d2753e6412 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3478150">Free Full Text </a></span></li><li><a name=ref-187 class=n-a></a><span class=label>187. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/727443417"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2753e6421 class=n-a></a>Sucksdorff M, Rissanen E, Tuisku J, <i> et al.</i>: Evaluation of the Effect of Fingolimod Treatment on Microglial Activation Using Serial PET Imaging in Multiple Sclerosis. <i>J Nucl Med.</i> 2017; <b>58</b>(10): 1646–1651. <a target=xrefwindow id=d2753e6432 href="http://www.ncbi.nlm.nih.gov/pubmed/28336784">PubMed Abstract </a> | <a target=xrefwindow id=d2753e6435 href="http://dx.doi.org/10.2967/jnumed.116.183020">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/727443417">F1000 Recommendation</a></span></li><li><a name=ref-188 class=n-a></a><span class=label>188. </span>&nbsp;<span class=citation><a name=d2753e6448 class=n-a></a>Tronel C, Largeau B, Santiago Ribeiro MJ, <i> et al.</i>: Molecular Targets for PET Imaging of Activated Microglia: The Current Situation and Future Expectations. <i>Int J Mol Sci.</i> 2017; <b>18</b>(4): pii: E802. <a target=xrefwindow id=d2753e6459 href="http://www.ncbi.nlm.nih.gov/pubmed/28398245">PubMed Abstract </a> | <a target=xrefwindow id=d2753e6462 href="http://dx.doi.org/10.3390/ijms18040802">Publisher Full Text </a> | <a target=xrefwindow id=d2753e6466 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5412386">Free Full Text </a></span></li><li><a name=ref-189 class=n-a></a><span class=label>189. </span>&nbsp;<span class=citation><a name=d2753e6475 class=n-a></a>Perry VH, Nicoll JA, Holmes C: Microglia in neurodegenerative disease. <i>Nat Rev Neurol.</i> 2010; <b>6</b>(4): 193–201. <a target=xrefwindow id=d2753e6483 href="http://www.ncbi.nlm.nih.gov/pubmed/20234358">PubMed Abstract </a> | <a target=xrefwindow id=d2753e6486 href="http://dx.doi.org/10.1038/nrneurol.2010.17">Publisher Full Text </a></span></li><li><a name=ref-190 class=n-a></a><span class=label>190. </span>&nbsp;<span class=citation><a name=d2753e6495 class=n-a></a>Price DA, Martinez AA, Seillier A, <i> et al.</i>: WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. <i>Eur J Neurosci.</i> 2009; <b>29</b>(11): 2177–86. <a target=xrefwindow id=d2753e6506 href="http://www.ncbi.nlm.nih.gov/pubmed/19490092">PubMed Abstract </a> | <a target=xrefwindow id=d2753e6509 href="http://dx.doi.org/10.1111/j.1460-9568.2009.06764.x">Publisher Full Text </a> | <a target=xrefwindow id=d2753e6513 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2755595">Free Full Text </a></span></li><li><a name=ref-191 class=n-a></a><span class=label>191. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/729695415"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2753e6522 class=n-a></a>Ahmad R, Postnov A, Bormans G, <i> et al.</i>: Decreased <i>in vivo</i> availability of the cannabinoid type 2 receptor in Alzheimer's disease. <i>Eur J Nucl Med Mol Imaging.</i> 2016; <b>43</b>(12): 2219–27. <a target=xrefwindow id=d2753e6536 href="http://www.ncbi.nlm.nih.gov/pubmed/27488857">PubMed Abstract </a> | <a target=xrefwindow id=d2753e6540 href="http://dx.doi.org/10.1007/s00259-016-3457-7">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/729695415">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 12 Oct 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-1830.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-1830.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Vita-Salute San Raffaele University, Milan, Italy<br/> <sup>2</sup> In Vivo Human Molecular and Structural Neuroimaging Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy<br/> <sup>3</sup> Nuclear Medicine Unit, IRCCS San Raffaele Hospital, Milan, Italy<br/> <p> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/6-1830/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 12 Oct 2017, 6:1830 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.11603.1">https://doi.org/10.12688/f1000research.11603.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2017 Iaccarino L <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=12533 data-id=11603 data-downloads="" data-views="" data-scholar="10.12688/f1000research.11603.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/6-1830/v1/pdf?article_uuid=2ed98459-8c61-4222-8ac2-363a8291901a" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.11603.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Iaccarino L, Sala A, Caminiti SP and Perani D. The emerging role of PET imaging in dementia [version 1; peer review: 3 approved] <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1830 (<a href="https://doi.org/10.12688/f1000research.11603.1" target=_blank>https://doi.org/10.12688/f1000research.11603.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=11603 id=mobile-track-article-signin-11603 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/11603?target=/articles/6-1830.html"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=12533 /> <input name=articleId type=hidden value=11603 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Adriaan Lammertsma</strong>, VU University Medical Center, The Netherlands </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Sabina Pappata</strong>, Institute of Biostructure and Bioimaging (IBB), Consiglio Nazionale delle Ricerche (CNR), Italy </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Karl Herholz</strong>, University of Manchester, UK </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 12 Oct 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-1830.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-1830.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=26793-26698></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=26792-26697></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=8696-26699></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=3><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> <th class="c-report-timeline__headings-version p-article__color--dark">3</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/6-1830/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>12 Oct 17</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Adriaan Lammertsma</strong>, VU University Medical Center, The Netherlands </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Sabina Pappata</strong>, Institute of Biostructure and Bioimaging (IBB), Consiglio Nazionale delle Ricerche (CNR), Italy </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Karl Herholz</strong>, University of Manchester, UK </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/6-1830.html&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/6-1830/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "The emerging role of PET imaging in dementia".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/6-1830/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/6-1830/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/6-1830/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Iaccarino L et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/6-1830/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/6-1830",
            templates : {
                twitter : "The emerging role of PET imaging in dementia. Iaccarino L et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/6-1830/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: The emerging role of PET imaging in dementia", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: The emerging role of PET imaging in dementia", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/11603/12533")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "12533");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "26697": 0,
                           "26698": 0,
                           "26699": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "e7a7dc0c-ef22-4344-8e0c-35a6be760cdb";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1830.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1830.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1830.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/6-1830.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/6-1830.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>